id	sid	tid	token	lemma	pos
cord-253746-15w4gquq	1	1	key	key	JJ
cord-253746-15w4gquq	1	2	:	:	:
cord-253746-15w4gquq	1	3	cord-253746	cord-253746	NNP
cord-253746-15w4gquq	1	4	-	-	HYPH
cord-253746-15w4gquq	1	5	15w4gquq	15w4gquq	CD
cord-253746-15w4gquq	1	6	authors	author	NNS
cord-253746-15w4gquq	1	7	:	:	:
cord-253746-15w4gquq	1	8	Goldman	Goldman	NNP
cord-253746-15w4gquq	1	9	,	,	,
cord-253746-15w4gquq	1	10	Michel	Michel	NNP
cord-253746-15w4gquq	1	11	;	;	:
cord-253746-15w4gquq	1	12	Silva	Silva	NNP
cord-253746-15w4gquq	1	13	,	,	,
cord-253746-15w4gquq	1	14	Mitchell	Mitchell	NNP
cord-253746-15w4gquq	1	15	title	title	NN
cord-253746-15w4gquq	1	16	:	:	:
cord-253746-15w4gquq	1	17	Reflections	reflection	NNS
cord-253746-15w4gquq	1	18	on	on	IN
cord-253746-15w4gquq	1	19	the	the	DT
cord-253746-15w4gquq	1	20	Collaborative	Collaborative	NNP
cord-253746-15w4gquq	1	21	Fight	Fight	NNP
cord-253746-15w4gquq	2	1	Against	against	IN
cord-253746-15w4gquq	2	2	COVID-19	covid-19	CD
cord-253746-15w4gquq	2	3	date	date	NN
cord-253746-15w4gquq	2	4	:	:	:
cord-253746-15w4gquq	2	5	2020	2020	CD
cord-253746-15w4gquq	2	6	-	-	HYPH
cord-253746-15w4gquq	2	7	09	09	CD
cord-253746-15w4gquq	2	8	-	-	SYM
cord-253746-15w4gquq	2	9	17	17	CD
cord-253746-15w4gquq	2	10	journal	journal	NN
cord-253746-15w4gquq	2	11	:	:	:
cord-253746-15w4gquq	3	1	Front	Front	NNP
cord-253746-15w4gquq	3	2	Med	Med	NNP
cord-253746-15w4gquq	3	3	(	(	-LRB-
cord-253746-15w4gquq	3	4	Lausanne	Lausanne	NNP
cord-253746-15w4gquq	3	5	)	)	-RRB-
cord-253746-15w4gquq	3	6	DOI	DOI	NNP
cord-253746-15w4gquq	3	7	:	:	:
cord-253746-15w4gquq	4	1	10.3389	10.3389	CD
cord-253746-15w4gquq	4	2	/	/	SYM
cord-253746-15w4gquq	4	3	fmed.2020.00565	fmed.2020.00565	NNS
cord-253746-15w4gquq	4	4	sha	sha	NNP
cord-253746-15w4gquq	4	5	:	:	:
cord-253746-15w4gquq	4	6	5e1fd8235fab26c9a799af0298a09e10e25f9c10	5e1fd8235fab26c9a799af0298a09e10e25f9c10	CD
cord-253746-15w4gquq	4	7	doc_id	doc_id	CD
cord-253746-15w4gquq	4	8	:	:	:
cord-253746-15w4gquq	5	1	253746	253746	CD
cord-253746-15w4gquq	5	2	cord_uid	cord_uid	NNS
cord-253746-15w4gquq	5	3	:	:	:
cord-253746-15w4gquq	6	1	15w4gquq	15w4gquq	CD
cord-253746-15w4gquq	6	2	Clinical	clinical	JJ
cord-253746-15w4gquq	6	3	trials	trial	NNS
cord-253746-15w4gquq	6	4	to	to	TO
cord-253746-15w4gquq	6	5	identify	identify	VB
cord-253746-15w4gquq	6	6	efficient	efficient	JJ
cord-253746-15w4gquq	6	7	treatments	treatment	NNS
cord-253746-15w4gquq	6	8	against	against	IN
cord-253746-15w4gquq	6	9	COVID-19	covid-19	JJ
cord-253746-15w4gquq	6	10	flourish	flourish	NN
cord-253746-15w4gquq	6	11	worldwide	worldwide	RB
cord-253746-15w4gquq	6	12	without	without	IN
cord-253746-15w4gquq	6	13	much	much	JJ
cord-253746-15w4gquq	6	14	attention	attention	NN
cord-253746-15w4gquq	6	15	to	to	IN
cord-253746-15w4gquq	6	16	patients	patient	NNS
cord-253746-15w4gquq	6	17	'	'	POS
cord-253746-15w4gquq	6	18	voice	voice	NN
cord-253746-15w4gquq	6	19	so	so	RB
cord-253746-15w4gquq	6	20	far	far	RB
cord-253746-15w4gquq	6	21	.	.	.
cord-253746-15w4gquq	7	1	As	as	IN
cord-253746-15w4gquq	7	2	therapeutic	therapeutic	JJ
cord-253746-15w4gquq	7	3	interventions	intervention	NNS
cord-253746-15w4gquq	7	4	in	in	IN
cord-253746-15w4gquq	7	5	the	the	DT
cord-253746-15w4gquq	7	6	early	early	JJ
cord-253746-15w4gquq	7	7	phase	phase	NN
cord-253746-15w4gquq	7	8	of	of	IN
cord-253746-15w4gquq	7	9	the	the	DT
cord-253746-15w4gquq	7	10	disease	disease	NN
cord-253746-15w4gquq	7	11	are	be	VBP
cord-253746-15w4gquq	7	12	attracting	attract	VBG
cord-253746-15w4gquq	7	13	more	more	JJR
cord-253746-15w4gquq	7	14	and	and	CC
cord-253746-15w4gquq	7	15	more	more	JJR
cord-253746-15w4gquq	7	16	interest	interest	NN
cord-253746-15w4gquq	7	17	,	,	,
cord-253746-15w4gquq	7	18	we	-PRON-	PRP
cord-253746-15w4gquq	7	19	argue	argue	VBP
cord-253746-15w4gquq	7	20	that	that	IN
cord-253746-15w4gquq	7	21	now	now	RB
cord-253746-15w4gquq	7	22	is	be	VBZ
cord-253746-15w4gquq	7	23	the	the	DT
cord-253746-15w4gquq	7	24	time	time	NN
cord-253746-15w4gquq	7	25	to	to	TO
cord-253746-15w4gquq	7	26	involve	involve	VB
cord-253746-15w4gquq	7	27	patients	patient	NNS
cord-253746-15w4gquq	7	28	'	'	POS
cord-253746-15w4gquq	7	29	organizations	organization	NNS
cord-253746-15w4gquq	7	30	in	in	IN
cord-253746-15w4gquq	7	31	the	the	DT
cord-253746-15w4gquq	7	32	design	design	NN
cord-253746-15w4gquq	7	33	of	of	IN
cord-253746-15w4gquq	7	34	clinical	clinical	JJ
cord-253746-15w4gquq	7	35	protocols	protocol	NNS
cord-253746-15w4gquq	7	36	in	in	IN
cord-253746-15w4gquq	7	37	order	order	NN
cord-253746-15w4gquq	7	38	to	to	TO
cord-253746-15w4gquq	7	39	define	define	VB
cord-253746-15w4gquq	7	40	the	the	DT
cord-253746-15w4gquq	7	41	most	most	RBS
cord-253746-15w4gquq	7	42	relevant	relevant	JJ
cord-253746-15w4gquq	7	43	end	end	NN
cord-253746-15w4gquq	7	44	-	-	HYPH
cord-253746-15w4gquq	7	45	points	point	NNS
cord-253746-15w4gquq	7	46	and	and	CC
cord-253746-15w4gquq	7	47	assess	assess	VB
cord-253746-15w4gquq	7	48	the	the	DT
cord-253746-15w4gquq	7	49	risk	risk	NN
cord-253746-15w4gquq	7	50	-	-	HYPH
cord-253746-15w4gquq	7	51	benefit	benefit	NN
cord-253746-15w4gquq	7	52	balance	balance	NN
cord-253746-15w4gquq	7	53	of	of	IN
cord-253746-15w4gquq	7	54	new	new	JJ
cord-253746-15w4gquq	7	55	therapies	therapy	NNS
cord-253746-15w4gquq	7	56	.	.	.
cord-253746-15w4gquq	8	1	Since	since	IN
cord-253746-15w4gquq	8	2	the	the	DT
cord-253746-15w4gquq	8	3	end	end	NN
cord-253746-15w4gquq	8	4	of	of	IN
cord-253746-15w4gquq	8	5	December	December	NNP
cord-253746-15w4gquq	8	6	2019	2019	CD
cord-253746-15w4gquq	8	7	when	when	WRB
cord-253746-15w4gquq	8	8	a	a	DT
cord-253746-15w4gquq	8	9	pneumonia	pneumonia	NN
cord-253746-15w4gquq	8	10	outbreak	outbreak	NN
cord-253746-15w4gquq	8	11	of	of	IN
cord-253746-15w4gquq	8	12	unknown	unknown	JJ
cord-253746-15w4gquq	8	13	origin	origin	NN
cord-253746-15w4gquq	8	14	was	be	VBD
cord-253746-15w4gquq	8	15	reported	report	VBN
cord-253746-15w4gquq	8	16	in	in	IN
cord-253746-15w4gquq	8	17	China	China	NNP
cord-253746-15w4gquq	8	18	,	,	,
cord-253746-15w4gquq	8	19	scientific	scientific	JJ
cord-253746-15w4gquq	8	20	knowledge	knowledge	NN
cord-253746-15w4gquq	8	21	on	on	IN
cord-253746-15w4gquq	8	22	COVID-19	COVID-19	NNP
cord-253746-15w4gquq	8	23	progressed	progress	VBD
cord-253746-15w4gquq	8	24	at	at	IN
cord-253746-15w4gquq	8	25	an	an	DT
cord-253746-15w4gquq	8	26	unprecedented	unprecedented	JJ
cord-253746-15w4gquq	8	27	pace	pace	NN
cord-253746-15w4gquq	8	28	.	.	.
cord-253746-15w4gquq	9	1	Within	within	IN
cord-253746-15w4gquq	9	2	a	a	DT
cord-253746-15w4gquq	9	3	few	few	JJ
cord-253746-15w4gquq	9	4	months	month	NNS
cord-253746-15w4gquq	9	5	,	,	,
cord-253746-15w4gquq	9	6	SARS	SARS	NNP
cord-253746-15w4gquq	9	7	-	-	HYPH
cord-253746-15w4gquq	9	8	CoV-2	CoV-2	NNP
cord-253746-15w4gquq	9	9	was	be	VBD
cord-253746-15w4gquq	9	10	identified	identify	VBN
cord-253746-15w4gquq	9	11	as	as	IN
cord-253746-15w4gquq	9	12	the	the	DT
cord-253746-15w4gquq	9	13	culprit	culprit	NN
cord-253746-15w4gquq	9	14	agent	agent	NN
cord-253746-15w4gquq	9	15	,	,	,
cord-253746-15w4gquq	9	16	mechanisms	mechanism	NNS
cord-253746-15w4gquq	9	17	by	by	IN
cord-253746-15w4gquq	9	18	which	which	WDT
cord-253746-15w4gquq	9	19	it	-PRON-	PRP
cord-253746-15w4gquq	9	20	infects	infect	VBZ
cord-253746-15w4gquq	9	21	cells	cell	NNS
cord-253746-15w4gquq	9	22	were	be	VBD
cord-253746-15w4gquq	9	23	deciphered	decipher	VBN
cord-253746-15w4gquq	9	24	and	and	CC
cord-253746-15w4gquq	9	25	causes	cause	NNS
cord-253746-15w4gquq	9	26	of	of	IN
cord-253746-15w4gquq	9	27	organ	organ	NN
cord-253746-15w4gquq	9	28	damage	damage	NN
cord-253746-15w4gquq	9	29	were	be	VBD
cord-253746-15w4gquq	9	30	identified	identify	VBN
cord-253746-15w4gquq	9	31	.	.	.
cord-253746-15w4gquq	10	1	This	this	DT
cord-253746-15w4gquq	10	2	has	have	VBZ
cord-253746-15w4gquq	10	3	been	be	VBN
cord-253746-15w4gquq	10	4	possible	possible	JJ
cord-253746-15w4gquq	10	5	because	because	IN
cord-253746-15w4gquq	10	6	scientific	scientific	JJ
cord-253746-15w4gquq	10	7	data	datum	NNS
cord-253746-15w4gquq	10	8	were	be	VBD
cord-253746-15w4gquq	10	9	never	never	RB
cord-253746-15w4gquq	10	10	shared	share	VBN
cord-253746-15w4gquq	10	11	so	so	RB
cord-253746-15w4gquq	10	12	quickly	quickly	RB
cord-253746-15w4gquq	10	13	and	and	CC
cord-253746-15w4gquq	10	14	transparently	transparently	RB
cord-253746-15w4gquq	10	15	,	,	,
cord-253746-15w4gquq	10	16	with	with	IN
cord-253746-15w4gquq	10	17	essential	essential	JJ
cord-253746-15w4gquq	10	18	results	result	NNS
cord-253746-15w4gquq	10	19	being	be	VBG
cord-253746-15w4gquq	10	20	exchanged	exchange	VBN
cord-253746-15w4gquq	10	21	and	and	CC
cord-253746-15w4gquq	10	22	made	make	VBN
cord-253746-15w4gquq	10	23	available	available	JJ
cord-253746-15w4gquq	10	24	in	in	IN
cord-253746-15w4gquq	10	25	real	real	JJ
cord-253746-15w4gquq	10	26	time	time	NN
cord-253746-15w4gquq	10	27	to	to	IN
cord-253746-15w4gquq	10	28	the	the	DT
cord-253746-15w4gquq	10	29	entire	entire	JJ
cord-253746-15w4gquq	10	30	scientific	scientific	JJ
cord-253746-15w4gquq	10	31	community	community	NN
cord-253746-15w4gquq	10	32	.	.	.
cord-253746-15w4gquq	11	1	Now	now	RB
cord-253746-15w4gquq	11	2	that	that	IN
cord-253746-15w4gquq	11	3	we	-PRON-	PRP
cord-253746-15w4gquq	11	4	enter	enter	VBP
cord-253746-15w4gquq	11	5	a	a	DT
cord-253746-15w4gquq	11	6	new	new	JJ
cord-253746-15w4gquq	11	7	phase	phase	NN
cord-253746-15w4gquq	11	8	during	during	IN
cord-253746-15w4gquq	11	9	which	which	WDT
cord-253746-15w4gquq	11	10	science	science	NN
cord-253746-15w4gquq	11	11	must	must	MD
cord-253746-15w4gquq	11	12	be	be	VB
cord-253746-15w4gquq	11	13	translated	translate	VBN
cord-253746-15w4gquq	11	14	in	in	IN
cord-253746-15w4gquq	11	15	innovative	innovative	JJ
cord-253746-15w4gquq	11	16	medicines	medicine	NNS
cord-253746-15w4gquq	11	17	and	and	CC
cord-253746-15w4gquq	11	18	vaccines	vaccine	NNS
cord-253746-15w4gquq	11	19	,	,	,
cord-253746-15w4gquq	11	20	a	a	DT
cord-253746-15w4gquq	11	21	key	key	JJ
cord-253746-15w4gquq	11	22	question	question	NN
cord-253746-15w4gquq	11	23	is	be	VBZ
cord-253746-15w4gquq	11	24	whether	whether	IN
cord-253746-15w4gquq	11	25	collective	collective	JJ
cord-253746-15w4gquq	11	26	intelligence	intelligence	NN
cord-253746-15w4gquq	11	27	will	will	MD
cord-253746-15w4gquq	11	28	remain	remain	VB
cord-253746-15w4gquq	11	29	mobilized	mobilize	VBN
cord-253746-15w4gquq	11	30	in	in	IN
cord-253746-15w4gquq	11	31	a	a	DT
cord-253746-15w4gquq	11	32	similar	similar	JJ
cord-253746-15w4gquq	11	33	manner	manner	NN
cord-253746-15w4gquq	11	34	.	.	.
cord-253746-15w4gquq	12	1	Indeed	indeed	RB
cord-253746-15w4gquq	12	2	,	,	,
cord-253746-15w4gquq	12	3	collaboration	collaboration	NN
cord-253746-15w4gquq	12	4	across	across	IN
cord-253746-15w4gquq	12	5	borders	border	NNS
cord-253746-15w4gquq	12	6	will	will	MD
cord-253746-15w4gquq	12	7	be	be	VB
cord-253746-15w4gquq	12	8	essential	essential	JJ
cord-253746-15w4gquq	12	9	to	to	TO
cord-253746-15w4gquq	12	10	overcome	overcome	VB
cord-253746-15w4gquq	12	11	COVID-19	COVID-19	NNP
cord-253746-15w4gquq	12	12	.	.	.
cord-253746-15w4gquq	13	1	Not	not	RB
cord-253746-15w4gquq	13	2	only	only	RB
cord-253746-15w4gquq	13	3	collaboration	collaboration	NN
cord-253746-15w4gquq	13	4	between	between	IN
cord-253746-15w4gquq	13	5	countries	country	NNS
cord-253746-15w4gquq	13	6	,	,	,
cord-253746-15w4gquq	13	7	but	but	CC
cord-253746-15w4gquq	13	8	also	also	RB
cord-253746-15w4gquq	13	9	between	between	IN
cord-253746-15w4gquq	13	10	academia	academia	NN
cord-253746-15w4gquq	13	11	and	and	CC
cord-253746-15w4gquq	13	12	industry	industry	NN
cord-253746-15w4gquq	13	13	,	,	,
cord-253746-15w4gquq	13	14	and	and	CC
cord-253746-15w4gquq	13	15	between	between	IN
cord-253746-15w4gquq	13	16	public	public	JJ
cord-253746-15w4gquq	13	17	and	and	CC
cord-253746-15w4gquq	13	18	private	private	JJ
cord-253746-15w4gquq	13	19	sectors	sector	NNS
cord-253746-15w4gquq	13	20	.	.	.
cord-253746-15w4gquq	14	1	The	the	DT
cord-253746-15w4gquq	14	2	challenge	challenge	NN
cord-253746-15w4gquq	14	3	is	be	VBZ
cord-253746-15w4gquq	14	4	not	not	RB
cord-253746-15w4gquq	14	5	only	only	RB
cord-253746-15w4gquq	14	6	to	to	TO
cord-253746-15w4gquq	14	7	discover	discover	VB
cord-253746-15w4gquq	14	8	the	the	DT
cord-253746-15w4gquq	14	9	right	right	JJ
cord-253746-15w4gquq	14	10	targets	target	NNS
cord-253746-15w4gquq	14	11	for	for	IN
cord-253746-15w4gquq	14	12	anti	anti	JJ
cord-253746-15w4gquq	14	13	-	-	JJ
cord-253746-15w4gquq	14	14	COVID-19	covid-19	JJ
cord-253746-15w4gquq	14	15	therapies	therapy	NNS
cord-253746-15w4gquq	14	16	and	and	CC
cord-253746-15w4gquq	14	17	vaccines	vaccine	NNS
cord-253746-15w4gquq	14	18	,	,	,
cord-253746-15w4gquq	14	19	but	but	CC
cord-253746-15w4gquq	14	20	also	also	RB
cord-253746-15w4gquq	14	21	to	to	TO
cord-253746-15w4gquq	14	22	ensure	ensure	VB
cord-253746-15w4gquq	14	23	that	that	IN
cord-253746-15w4gquq	14	24	the	the	DT
cord-253746-15w4gquq	14	25	new	new	JJ
cord-253746-15w4gquq	14	26	products	product	NNS
cord-253746-15w4gquq	14	27	will	will	MD
cord-253746-15w4gquq	14	28	be	be	VB
cord-253746-15w4gquq	14	29	both	both	DT
cord-253746-15w4gquq	14	30	efficient	efficient	JJ
cord-253746-15w4gquq	14	31	and	and	CC
cord-253746-15w4gquq	14	32	safe	safe	JJ
cord-253746-15w4gquq	14	33	,	,	,
cord-253746-15w4gquq	14	34	that	that	IN
cord-253746-15w4gquq	14	35	they	-PRON-	PRP
cord-253746-15w4gquq	14	36	can	can	MD
cord-253746-15w4gquq	14	37	be	be	VB
cord-253746-15w4gquq	14	38	manufactured	manufacture	VBN
cord-253746-15w4gquq	14	39	at	at	IN
cord-253746-15w4gquq	14	40	full	full	JJ
cord-253746-15w4gquq	14	41	industrial	industrial	JJ
cord-253746-15w4gquq	14	42	scale	scale	NN
cord-253746-15w4gquq	14	43	,	,	,
cord-253746-15w4gquq	14	44	and	and	CC
cord-253746-15w4gquq	14	45	that	that	IN
cord-253746-15w4gquq	14	46	they	-PRON-	PRP
cord-253746-15w4gquq	14	47	will	will	MD
cord-253746-15w4gquq	14	48	be	be	VB
cord-253746-15w4gquq	14	49	accessible	accessible	JJ
cord-253746-15w4gquq	14	50	worldwide	worldwide	RB
cord-253746-15w4gquq	14	51	at	at	IN
cord-253746-15w4gquq	14	52	affordable	affordable	JJ
cord-253746-15w4gquq	14	53	prices	price	NNS
cord-253746-15w4gquq	14	54	.	.	.
cord-253746-15w4gquq	15	1	Several	several	JJ
cord-253746-15w4gquq	15	2	initiatives	initiative	NNS
cord-253746-15w4gquq	15	3	have	have	VBP
cord-253746-15w4gquq	15	4	been	be	VBN
cord-253746-15w4gquq	15	5	launched	launch	VBN
cord-253746-15w4gquq	15	6	to	to	TO
cord-253746-15w4gquq	15	7	meet	meet	VB
cord-253746-15w4gquq	15	8	this	this	DT
cord-253746-15w4gquq	15	9	challenge	challenge	NN
cord-253746-15w4gquq	15	10	and	and	CC
cord-253746-15w4gquq	15	11	provide	provide	VB
cord-253746-15w4gquq	15	12	incentives	incentive	NNS
cord-253746-15w4gquq	15	13	to	to	TO
cord-253746-15w4gquq	15	14	foster	foster	VB
cord-253746-15w4gquq	15	15	collaborative	collaborative	JJ
cord-253746-15w4gquq	15	16	endeavors	endeavor	NNS
cord-253746-15w4gquq	15	17	.	.	.
cord-253746-15w4gquq	16	1	Both	both	DT
cord-253746-15w4gquq	16	2	the	the	DT
cord-253746-15w4gquq	16	3	"	"	``
cord-253746-15w4gquq	16	4	Accelerating	accelerate	VBG
cord-253746-15w4gquq	16	5	COVID-19	COVID-19	NNP
cord-253746-15w4gquq	16	6	Therapeutic	Therapeutic	NNP
cord-253746-15w4gquq	16	7	Interventions	Interventions	NNPS
cord-253746-15w4gquq	16	8	and	and	CC
cord-253746-15w4gquq	16	9	Vaccines	Vaccines	NNPS
cord-253746-15w4gquq	16	10	"	"	''
cord-253746-15w4gquq	16	11	(	(	-LRB-
cord-253746-15w4gquq	16	12	ACTIV	ACTIV	NNP
cord-253746-15w4gquq	16	13	)	)	-RRB-
cord-253746-15w4gquq	16	14	initiative	initiative	NN
cord-253746-15w4gquq	16	15	in	in	IN
cord-253746-15w4gquq	16	16	the	the	DT
cord-253746-15w4gquq	16	17	USA	USA	NNP
cord-253746-15w4gquq	16	18	(	(	-LRB-
cord-253746-15w4gquq	16	19	1	1	CD
cord-253746-15w4gquq	16	20	)	)	-RRB-
cord-253746-15w4gquq	16	21	and	and	CC
cord-253746-15w4gquq	16	22	the	the	DT
cord-253746-15w4gquq	16	23	"	"	``
cord-253746-15w4gquq	16	24	Coronavirus	Coronavirus	NNP
cord-253746-15w4gquq	16	25	Global	Global	NNP
cord-253746-15w4gquq	16	26	Response	Response	NNP
cord-253746-15w4gquq	16	27	"	"	''
cord-253746-15w4gquq	16	28	launched	launch	VBN
cord-253746-15w4gquq	16	29	by	by	IN
cord-253746-15w4gquq	16	30	the	the	DT
cord-253746-15w4gquq	16	31	European	European	NNP
cord-253746-15w4gquq	16	32	Commission	Commission	NNP
cord-253746-15w4gquq	16	33	(	(	-LRB-
cord-253746-15w4gquq	16	34	https://global-response.europa.eu/index_en	https://global-response.europa.eu/index_en	NFP
cord-253746-15w4gquq	16	35	)	)	-RRB-
cord-253746-15w4gquq	16	36	will	will	MD
cord-253746-15w4gquq	16	37	support	support	VB
cord-253746-15w4gquq	16	38	publicprivate	publicprivate	NN
cord-253746-15w4gquq	16	39	partnerships	partnership	NNS
cord-253746-15w4gquq	16	40	and	and	CC
cord-253746-15w4gquq	16	41	multi	multi	JJ
cord-253746-15w4gquq	16	42	-	-	JJ
cord-253746-15w4gquq	16	43	stakeholder	stakeholder	NN
cord-253746-15w4gquq	16	44	consortia	consortium	NNS
cord-253746-15w4gquq	16	45	.	.	.
cord-253746-15w4gquq	17	1	In	in	IN
cord-253746-15w4gquq	17	2	this	this	DT
cord-253746-15w4gquq	17	3	editorial	editorial	JJ
cord-253746-15w4gquq	17	4	perspective	perspective	NN
cord-253746-15w4gquq	17	5	,	,	,
cord-253746-15w4gquq	17	6	we	-PRON-	PRP
cord-253746-15w4gquq	17	7	argue	argue	VBP
cord-253746-15w4gquq	17	8	that	that	IN
cord-253746-15w4gquq	17	9	patients	patient	NNS
cord-253746-15w4gquq	17	10	'	'	POS
cord-253746-15w4gquq	17	11	voice	voice	NN
cord-253746-15w4gquq	17	12	will	will	MD
cord-253746-15w4gquq	17	13	be	be	VB
cord-253746-15w4gquq	17	14	essential	essential	JJ
cord-253746-15w4gquq	17	15	to	to	TO
cord-253746-15w4gquq	17	16	ensure	ensure	VB
cord-253746-15w4gquq	17	17	uptake	uptake	NN
cord-253746-15w4gquq	17	18	in	in	IN
cord-253746-15w4gquq	17	19	the	the	DT
cord-253746-15w4gquq	17	20	wider	wide	JJR
cord-253746-15w4gquq	17	21	public	public	NN
cord-253746-15w4gquq	17	22	of	of	IN
cord-253746-15w4gquq	17	23	new	new	JJ
cord-253746-15w4gquq	17	24	therapies	therapy	NNS
cord-253746-15w4gquq	17	25	and	and	CC
cord-253746-15w4gquq	17	26	vaccines	vaccine	NNS
cord-253746-15w4gquq	17	27	resulting	result	VBG
cord-253746-15w4gquq	17	28	from	from	IN
cord-253746-15w4gquq	17	29	these	these	DT
cord-253746-15w4gquq	17	30	initiatives	initiative	NNS
cord-253746-15w4gquq	17	31	.	.	.
cord-253746-15w4gquq	18	1	During	during	IN
cord-253746-15w4gquq	18	2	the	the	DT
cord-253746-15w4gquq	18	3	exploding	explode	VBG
cord-253746-15w4gquq	18	4	phase	phase	NN
cord-253746-15w4gquq	18	5	of	of	IN
cord-253746-15w4gquq	18	6	the	the	DT
cord-253746-15w4gquq	18	7	pandemic	pandemic	NN
cord-253746-15w4gquq	18	8	,	,	,
cord-253746-15w4gquq	18	9	the	the	DT
cord-253746-15w4gquq	18	10	immediate	immediate	JJ
cord-253746-15w4gquq	18	11	priority	priority	NN
cord-253746-15w4gquq	18	12	was	be	VBD
cord-253746-15w4gquq	18	13	to	to	TO
cord-253746-15w4gquq	18	14	identify	identify	VB
cord-253746-15w4gquq	18	15	compounds	compound	NNS
cord-253746-15w4gquq	18	16	able	able	JJ
cord-253746-15w4gquq	18	17	to	to	TO
cord-253746-15w4gquq	18	18	mitigate	mitigate	VB
cord-253746-15w4gquq	18	19	the	the	DT
cord-253746-15w4gquq	18	20	most	most	RBS
cord-253746-15w4gquq	18	21	severe	severe	JJ
cord-253746-15w4gquq	18	22	cases	case	NNS
cord-253746-15w4gquq	18	23	of	of	IN
cord-253746-15w4gquq	18	24	COVID-19	covid-19	NN
cord-253746-15w4gquq	18	25	.	.	.
cord-253746-15w4gquq	19	1	Indeed	indeed	RB
cord-253746-15w4gquq	19	2	,	,	,
cord-253746-15w4gquq	19	3	doctors	doctor	NNS
cord-253746-15w4gquq	19	4	facing	face	VBG
cord-253746-15w4gquq	19	5	patients	patient	NNS
cord-253746-15w4gquq	19	6	dying	die	VBG
cord-253746-15w4gquq	19	7	of	of	IN
cord-253746-15w4gquq	19	8	fulminant	fulminant	JJ
cord-253746-15w4gquq	19	9	pneumonia	pneumonia	NN
cord-253746-15w4gquq	19	10	desperately	desperately	RB
cord-253746-15w4gquq	19	11	look	look	VBP
cord-253746-15w4gquq	19	12	for	for	IN
cord-253746-15w4gquq	19	13	potential	potential	JJ
cord-253746-15w4gquq	19	14	therapies	therapy	NNS
cord-253746-15w4gquq	19	15	that	that	WDT
cord-253746-15w4gquq	19	16	can	can	MD
cord-253746-15w4gquq	19	17	be	be	VB
cord-253746-15w4gquq	19	18	immediately	immediately	RB
cord-253746-15w4gquq	19	19	available	available	JJ
cord-253746-15w4gquq	19	20	.	.	.
cord-253746-15w4gquq	20	1	Unfortunately	unfortunately	RB
cord-253746-15w4gquq	20	2	,	,	,
cord-253746-15w4gquq	20	3	the	the	DT
cord-253746-15w4gquq	20	4	overall	overall	JJ
cord-253746-15w4gquq	20	5	outcome	outcome	NN
cord-253746-15w4gquq	20	6	of	of	IN
cord-253746-15w4gquq	20	7	the	the	DT
cord-253746-15w4gquq	20	8	clinical	clinical	JJ
cord-253746-15w4gquq	20	9	trials	trial	NNS
cord-253746-15w4gquq	20	10	conducted	conduct	VBN
cord-253746-15w4gquq	20	11	during	during	IN
cord-253746-15w4gquq	20	12	the	the	DT
cord-253746-15w4gquq	20	13	initial	initial	JJ
cord-253746-15w4gquq	20	14	phase	phase	NN
cord-253746-15w4gquq	20	15	of	of	IN
cord-253746-15w4gquq	20	16	the	the	DT
cord-253746-15w4gquq	20	17	pandemic	pandemic	NN
cord-253746-15w4gquq	20	18	was	be	VBD
cord-253746-15w4gquq	20	19	by	by	IN
cord-253746-15w4gquq	20	20	and	and	CC
cord-253746-15w4gquq	20	21	large	large	JJ
cord-253746-15w4gquq	20	22	disappointing	disappointing	JJ
cord-253746-15w4gquq	20	23	.	.	.
cord-253746-15w4gquq	21	1	A	a	DT
cord-253746-15w4gquq	21	2	huge	huge	JJ
cord-253746-15w4gquq	21	3	number	number	NN
cord-253746-15w4gquq	21	4	of	of	IN
cord-253746-15w4gquq	21	5	small	small	JJ
cord-253746-15w4gquq	21	6	statistically	statistically	RB
cord-253746-15w4gquq	21	7	underpowered	underpowered	JJ
cord-253746-15w4gquq	21	8	trials	trial	NNS
cord-253746-15w4gquq	21	9	were	be	VBD
cord-253746-15w4gquq	21	10	simultaneously	simultaneously	RB
cord-253746-15w4gquq	21	11	launched	launch	VBN
cord-253746-15w4gquq	21	12	(	(	-LRB-
cord-253746-15w4gquq	21	13	2	2	CD
cord-253746-15w4gquq	21	14	)	)	-RRB-
cord-253746-15w4gquq	21	15	and	and	CC
cord-253746-15w4gquq	21	16	a	a	DT
cord-253746-15w4gquq	21	17	recent	recent	JJ
cord-253746-15w4gquq	21	18	paper	paper	NN
cord-253746-15w4gquq	21	19	reported	report	VBD
cord-253746-15w4gquq	21	20	that	that	IN
cord-253746-15w4gquq	21	21	only	only	RB
cord-253746-15w4gquq	21	22	30	30	CD
cord-253746-15w4gquq	21	23	out	out	IN
cord-253746-15w4gquq	21	24	of	of	IN
cord-253746-15w4gquq	21	25	1,840	1,840	CD
cord-253746-15w4gquq	21	26	registered	register	VBN
cord-253746-15w4gquq	21	27	trials	trial	NNS
cord-253746-15w4gquq	21	28	have	have	VBP
cord-253746-15w4gquq	21	29	actually	actually	RB
cord-253746-15w4gquq	21	30	been	be	VBN
cord-253746-15w4gquq	21	31	reported	report	VBN
cord-253746-15w4gquq	21	32	,	,	,
cord-253746-15w4gquq	21	33	and	and	CC
cord-253746-15w4gquq	21	34	very	very	RB
cord-253746-15w4gquq	21	35	few	few	JJ
cord-253746-15w4gquq	21	36	trials	trial	NNS
cord-253746-15w4gquq	21	37	addressed	address	VBD
cord-253746-15w4gquq	21	38	early	early	JJ
cord-253746-15w4gquq	21	39	interventions	intervention	NNS
cord-253746-15w4gquq	21	40	aiming	aim	VBG
cord-253746-15w4gquq	21	41	at	at	IN
cord-253746-15w4gquq	21	42	preventing	prevent	VBG
cord-253746-15w4gquq	21	43	hospitalization	hospitalization	NN
cord-253746-15w4gquq	21	44	(	(	-LRB-
cord-253746-15w4gquq	21	45	3	3	CD
cord-253746-15w4gquq	21	46	)	)	-RRB-
cord-253746-15w4gquq	21	47	.	.	.
cord-253746-15w4gquq	22	1	The	the	DT
cord-253746-15w4gquq	22	2	most	most	RBS
cord-253746-15w4gquq	22	3	pertinent	pertinent	JJ
cord-253746-15w4gquq	22	4	trials	trial	NNS
cord-253746-15w4gquq	22	5	were	be	VBD
cord-253746-15w4gquq	22	6	the	the	DT
cord-253746-15w4gquq	22	7	so	so	RB
cord-253746-15w4gquq	22	8	-	-	HYPH
cord-253746-15w4gquq	22	9	called	call	VBN
cord-253746-15w4gquq	22	10	adaptive	adaptive	JJ
cord-253746-15w4gquq	22	11	trials	trial	NNS
cord-253746-15w4gquq	22	12	which	which	WDT
cord-253746-15w4gquq	22	13	conciliate	conciliate	VBP
cord-253746-15w4gquq	22	14	the	the	DT
cord-253746-15w4gquq	22	15	scientific	scientific	JJ
cord-253746-15w4gquq	22	16	rigor	rigor	NN
cord-253746-15w4gquq	22	17	brought	bring	VBN
cord-253746-15w4gquq	22	18	by	by	IN
cord-253746-15w4gquq	22	19	randomization	randomization	NN
cord-253746-15w4gquq	22	20	and	and	CC
cord-253746-15w4gquq	22	21	the	the	DT
cord-253746-15w4gquq	22	22	ethical	ethical	JJ
cord-253746-15w4gquq	22	23	duty	duty	NN
cord-253746-15w4gquq	22	24	to	to	TO
cord-253746-15w4gquq	22	25	provide	provide	VB
cord-253746-15w4gquq	22	26	patients	patient	NNS
cord-253746-15w4gquq	22	27	with	with	IN
cord-253746-15w4gquq	22	28	a	a	DT
cord-253746-15w4gquq	22	29	potentially	potentially	RB
cord-253746-15w4gquq	22	30	beneficial	beneficial	JJ
cord-253746-15w4gquq	22	31	therapy	therapy	NN
cord-253746-15w4gquq	22	32	.	.	.
cord-253746-15w4gquq	23	1	Indeed	indeed	RB
cord-253746-15w4gquq	23	2	,	,	,
cord-253746-15w4gquq	23	3	adaptive	adaptive	JJ
cord-253746-15w4gquq	23	4	trial	trial	NN
cord-253746-15w4gquq	23	5	designs	design	NNS
cord-253746-15w4gquq	23	6	allow	allow	VBP
cord-253746-15w4gquq	23	7	to	to	TO
cord-253746-15w4gquq	23	8	change	change	VB
cord-253746-15w4gquq	23	9	therapeutic	therapeutic	JJ
cord-253746-15w4gquq	23	10	options	option	NNS
cord-253746-15w4gquq	23	11	in	in	IN
cord-253746-15w4gquq	23	12	the	the	DT
cord-253746-15w4gquq	23	13	course	course	NN
cord-253746-15w4gquq	23	14	of	of	IN
cord-253746-15w4gquq	23	15	a	a	DT
cord-253746-15w4gquq	23	16	study	study	NN
cord-253746-15w4gquq	23	17	according	accord	VBG
cord-253746-15w4gquq	23	18	to	to	IN
cord-253746-15w4gquq	23	19	interim	interim	JJ
cord-253746-15w4gquq	23	20	evaluations	evaluation	NNS
cord-253746-15w4gquq	23	21	and	and	CC
cord-253746-15w4gquq	23	22	inefficient	inefficient	JJ
cord-253746-15w4gquq	23	23	treatments	treatment	NNS
cord-253746-15w4gquq	23	24	can	can	MD
cord-253746-15w4gquq	23	25	be	be	VB
cord-253746-15w4gquq	23	26	withdrawn	withdraw	VBN
cord-253746-15w4gquq	23	27	whereas	whereas	IN
cord-253746-15w4gquq	23	28	newly	newly	RB
cord-253746-15w4gquq	23	29	emerging	emerge	VBG
cord-253746-15w4gquq	23	30	therapies	therapy	NNS
cord-253746-15w4gquq	23	31	can	can	MD
cord-253746-15w4gquq	23	32	be	be	VB
cord-253746-15w4gquq	23	33	introduced	introduce	VBN
cord-253746-15w4gquq	23	34	in	in	IN
cord-253746-15w4gquq	23	35	the	the	DT
cord-253746-15w4gquq	23	36	trial	trial	NN
cord-253746-15w4gquq	23	37	(	(	-LRB-
cord-253746-15w4gquq	23	38	4	4	CD
cord-253746-15w4gquq	23	39	)	)	-RRB-
cord-253746-15w4gquq	23	40	.	.	.
cord-253746-15w4gquq	24	1	Three	three	CD
cord-253746-15w4gquq	24	2	large	large	JJ
cord-253746-15w4gquq	24	3	trials	trial	NNS
cord-253746-15w4gquq	24	4	using	use	VBG
cord-253746-15w4gquq	24	5	such	such	PDT
cord-253746-15w4gquq	24	6	an	an	DT
cord-253746-15w4gquq	24	7	adaptive	adaptive	JJ
cord-253746-15w4gquq	24	8	design	design	NN
cord-253746-15w4gquq	24	9	were	be	VBD
cord-253746-15w4gquq	24	10	launched	launch	VBN
cord-253746-15w4gquq	24	11	,	,	,
cord-253746-15w4gquq	24	12	Solidarity	Solidarity	NNP
cord-253746-15w4gquq	24	13	led	lead	VBD
cord-253746-15w4gquq	24	14	by	by	IN
cord-253746-15w4gquq	24	15	the	the	DT
cord-253746-15w4gquq	24	16	World	World	NNP
cord-253746-15w4gquq	24	17	Health	Health	NNP
cord-253746-15w4gquq	24	18	organization	organization	NN
cord-253746-15w4gquq	24	19	(	(	-LRB-
cord-253746-15w4gquq	24	20	WHO	who	WP
cord-253746-15w4gquq	24	21	)	)	-RRB-
cord-253746-15w4gquq	24	22	,	,	,
cord-253746-15w4gquq	24	23	Discovery	Discovery	NNP
cord-253746-15w4gquq	24	24	by	by	IN
cord-253746-15w4gquq	24	25	the	the	DT
cord-253746-15w4gquq	24	26	French	French	NNP
cord-253746-15w4gquq	24	27	Institute	Institute	NNP
cord-253746-15w4gquq	24	28	for	for	IN
cord-253746-15w4gquq	24	29	Health	Health	NNP
cord-253746-15w4gquq	24	30	and	and	CC
cord-253746-15w4gquq	24	31	Medical	Medical	NNP
cord-253746-15w4gquq	24	32	Research	Research	NNP
cord-253746-15w4gquq	24	33	(	(	-LRB-
cord-253746-15w4gquq	24	34	INSERM	INSERM	NNP
cord-253746-15w4gquq	24	35	)	)	-RRB-
cord-253746-15w4gquq	24	36	,	,	,
cord-253746-15w4gquq	24	37	and	and	CC
cord-253746-15w4gquq	24	38	Recovery	Recovery	NNP
cord-253746-15w4gquq	24	39	by	by	IN
cord-253746-15w4gquq	24	40	the	the	DT
cord-253746-15w4gquq	24	41	University	University	NNP
cord-253746-15w4gquq	24	42	of	of	IN
cord-253746-15w4gquq	24	43	Oxford	Oxford	NNP
cord-253746-15w4gquq	24	44	.	.	.
cord-253746-15w4gquq	25	1	Unfortunately	unfortunately	RB
cord-253746-15w4gquq	25	2	,	,	,
cord-253746-15w4gquq	25	3	the	the	DT
cord-253746-15w4gquq	25	4	implementation	implementation	NN
cord-253746-15w4gquq	25	5	of	of	IN
cord-253746-15w4gquq	25	6	Solidarity	Solidarity	NNP
cord-253746-15w4gquq	25	7	and	and	CC
cord-253746-15w4gquq	25	8	Discovery	Discovery	NNP
cord-253746-15w4gquq	25	9	were	be	VBD
cord-253746-15w4gquq	25	10	hampered	hamper	VBN
cord-253746-15w4gquq	25	11	by	by	IN
cord-253746-15w4gquq	25	12	regulatory	regulatory	JJ
cord-253746-15w4gquq	25	13	and	and	CC
cord-253746-15w4gquq	25	14	administrative	administrative	JJ
cord-253746-15w4gquq	25	15	hurdles	hurdle	NNS
cord-253746-15w4gquq	25	16	.	.	.
cord-253746-15w4gquq	26	1	On	on	IN
cord-253746-15w4gquq	26	2	the	the	DT
cord-253746-15w4gquq	26	3	other	other	JJ
cord-253746-15w4gquq	26	4	hand	hand	NN
cord-253746-15w4gquq	26	5	,	,	,
cord-253746-15w4gquq	26	6	Recovery	Recovery	NNP
cord-253746-15w4gquq	26	7	provided	provide	VBD
cord-253746-15w4gquq	26	8	an	an	DT
cord-253746-15w4gquq	26	9	essential	essential	JJ
cord-253746-15w4gquq	26	10	information	information	NN
cord-253746-15w4gquq	26	11	for	for	IN
cord-253746-15w4gquq	26	12	the	the	DT
cord-253746-15w4gquq	26	13	management	management	NN
cord-253746-15w4gquq	26	14	of	of	IN
cord-253746-15w4gquq	26	15	future	future	JJ
cord-253746-15w4gquq	26	16	cases	case	NNS
cord-253746-15w4gquq	26	17	by	by	IN
cord-253746-15w4gquq	26	18	demonstrating	demonstrate	VBG
cord-253746-15w4gquq	26	19	the	the	DT
cord-253746-15w4gquq	26	20	beneficial	beneficial	JJ
cord-253746-15w4gquq	26	21	action	action	NN
cord-253746-15w4gquq	26	22	of	of	IN
cord-253746-15w4gquq	26	23	dexamethasone	dexamethasone	NN
cord-253746-15w4gquq	26	24	in	in	IN
cord-253746-15w4gquq	26	25	reducing	reduce	VBG
cord-253746-15w4gquq	26	26	the	the	DT
cord-253746-15w4gquq	26	27	mortality	mortality	NN
cord-253746-15w4gquq	26	28	of	of	IN
cord-253746-15w4gquq	26	29	patients	patient	NNS
cord-253746-15w4gquq	26	30	with	with	IN
cord-253746-15w4gquq	26	31	the	the	DT
cord-253746-15w4gquq	26	32	most	most	RBS
cord-253746-15w4gquq	26	33	severe	severe	JJ
cord-253746-15w4gquq	26	34	forms	form	NNS
cord-253746-15w4gquq	26	35	of	of	IN
cord-253746-15w4gquq	26	36	the	the	DT
cord-253746-15w4gquq	26	37	disease	disease	NN
cord-253746-15w4gquq	26	38	(	(	-LRB-
cord-253746-15w4gquq	26	39	5	5	CD
cord-253746-15w4gquq	26	40	)	)	-RRB-
cord-253746-15w4gquq	26	41	.	.	.
cord-253746-15w4gquq	27	1	Remdesivir	Remdesivir	NNP
cord-253746-15w4gquq	27	2	is	be	VBZ
cord-253746-15w4gquq	27	3	the	the	DT
cord-253746-15w4gquq	27	4	other	other	JJ
cord-253746-15w4gquq	27	5	treatment	treatment	NN
cord-253746-15w4gquq	27	6	which	which	WDT
cord-253746-15w4gquq	27	7	has	have	VBZ
cord-253746-15w4gquq	27	8	been	be	VBN
cord-253746-15w4gquq	27	9	scientifically	scientifically	RB
cord-253746-15w4gquq	27	10	validated	validate	VBN
cord-253746-15w4gquq	27	11	in	in	IN
cord-253746-15w4gquq	27	12	a	a	DT
cord-253746-15w4gquq	27	13	randomized	randomized	JJ
cord-253746-15w4gquq	27	14	study	study	NN
cord-253746-15w4gquq	27	15	,	,	,
cord-253746-15w4gquq	27	16	again	again	RB
cord-253746-15w4gquq	27	17	in	in	IN
cord-253746-15w4gquq	27	18	hospitalized	hospitalize	VBN
cord-253746-15w4gquq	27	19	patients	patient	NNS
cord-253746-15w4gquq	27	20	with	with	IN
cord-253746-15w4gquq	27	21	serious	serious	JJ
cord-253746-15w4gquq	27	22	illness	illness	NN
cord-253746-15w4gquq	27	23	(	(	-LRB-
cord-253746-15w4gquq	27	24	6	6	CD
cord-253746-15w4gquq	27	25	)	)	-RRB-
cord-253746-15w4gquq	27	26	.	.	.
cord-253746-15w4gquq	28	1	While	while	IN
cord-253746-15w4gquq	28	2	a	a	DT
cord-253746-15w4gquq	28	3	number	number	NN
cord-253746-15w4gquq	28	4	of	of	IN
cord-253746-15w4gquq	28	5	countries	country	NNS
cord-253746-15w4gquq	28	6	are	be	VBP
cord-253746-15w4gquq	28	7	still	still	RB
cord-253746-15w4gquq	28	8	in	in	IN
cord-253746-15w4gquq	28	9	the	the	DT
cord-253746-15w4gquq	28	10	ascending	ascending	JJ
cord-253746-15w4gquq	28	11	limb	limb	NN
cord-253746-15w4gquq	28	12	of	of	IN
cord-253746-15w4gquq	28	13	the	the	DT
cord-253746-15w4gquq	28	14	pandemic	pandemic	NN
cord-253746-15w4gquq	28	15	and	and	CC
cord-253746-15w4gquq	28	16	several	several	JJ
cord-253746-15w4gquq	28	17	others	other	NNS
cord-253746-15w4gquq	28	18	face	face	VBP
cord-253746-15w4gquq	28	19	resurgence	resurgence	NN
cord-253746-15w4gquq	28	20	of	of	IN
cord-253746-15w4gquq	28	21	new	new	JJ
cord-253746-15w4gquq	28	22	cases	case	NNS
cord-253746-15w4gquq	28	23	,	,	,
cord-253746-15w4gquq	28	24	now	now	RB
cord-253746-15w4gquq	28	25	is	be	VBZ
cord-253746-15w4gquq	28	26	the	the	DT
cord-253746-15w4gquq	28	27	time	time	NN
cord-253746-15w4gquq	28	28	to	to	TO
cord-253746-15w4gquq	28	29	reflect	reflect	VB
cord-253746-15w4gquq	28	30	on	on	IN
cord-253746-15w4gquq	28	31	how	how	WRB
cord-253746-15w4gquq	28	32	to	to	TO
cord-253746-15w4gquq	28	33	make	make	VB
cord-253746-15w4gquq	28	34	the	the	DT
cord-253746-15w4gquq	28	35	search	search	NN
cord-253746-15w4gquq	28	36	for	for	IN
cord-253746-15w4gquq	28	37	new	new	JJ
cord-253746-15w4gquq	28	38	COVID-19	COVID-19	NNP
cord-253746-15w4gquq	28	39	therapies	therapy	NNS
cord-253746-15w4gquq	28	40	more	more	RBR
cord-253746-15w4gquq	28	41	efficient	efficient	JJ
cord-253746-15w4gquq	28	42	(	(	-LRB-
cord-253746-15w4gquq	28	43	7	7	CD
cord-253746-15w4gquq	28	44	)	)	-RRB-
cord-253746-15w4gquq	28	45	.	.	.
cord-253746-15w4gquq	29	1	Fore	Fore	NNS
cord-253746-15w4gquq	29	2	and	and	CC
cord-253746-15w4gquq	29	3	foremost	foremost	RB
cord-253746-15w4gquq	29	4	,	,	,
cord-253746-15w4gquq	29	5	radical	radical	JJ
cord-253746-15w4gquq	29	6	changes	change	NNS
cord-253746-15w4gquq	29	7	are	be	VBP
cord-253746-15w4gquq	29	8	necessary	necessary	JJ
cord-253746-15w4gquq	29	9	to	to	TO
cord-253746-15w4gquq	29	10	prevent	prevent	VB
cord-253746-15w4gquq	29	11	a	a	DT
cord-253746-15w4gquq	29	12	detrimental	detrimental	JJ
cord-253746-15w4gquq	29	13	competition	competition	NN
cord-253746-15w4gquq	29	14	between	between	IN
cord-253746-15w4gquq	29	15	trials	trial	NNS
cord-253746-15w4gquq	29	16	that	that	WDT
cord-253746-15w4gquq	29	17	are	be	VBP
cord-253746-15w4gquq	29	18	either	either	CC
cord-253746-15w4gquq	29	19	underpowered	underpowered	JJ
cord-253746-15w4gquq	29	20	or	or	CC
cord-253746-15w4gquq	29	21	unrealistic	unrealistic	JJ
cord-253746-15w4gquq	29	22	in	in	IN
cord-253746-15w4gquq	29	23	terms	term	NNS
cord-253746-15w4gquq	29	24	of	of	IN
cord-253746-15w4gquq	29	25	patient	patient	JJ
cord-253746-15w4gquq	29	26	accrual	accrual	NN
cord-253746-15w4gquq	29	27	.	.	.
cord-253746-15w4gquq	30	1	This	this	DT
cord-253746-15w4gquq	30	2	is	be	VBZ
cord-253746-15w4gquq	30	3	an	an	DT
cord-253746-15w4gquq	30	4	ethical	ethical	JJ
cord-253746-15w4gquq	30	5	duty	duty	NN
cord-253746-15w4gquq	30	6	toward	toward	IN
cord-253746-15w4gquq	30	7	patients	patient	NNS
cord-253746-15w4gquq	30	8	which	which	WDT
cord-253746-15w4gquq	30	9	agree	agree	VBP
cord-253746-15w4gquq	30	10	to	to	TO
cord-253746-15w4gquq	30	11	be	be	VB
cord-253746-15w4gquq	30	12	exposed	expose	VBN
cord-253746-15w4gquq	30	13	to	to	IN
cord-253746-15w4gquq	30	14	potential	potential	JJ
cord-253746-15w4gquq	30	15	risks	risk	NNS
cord-253746-15w4gquq	30	16	with	with	IN
cord-253746-15w4gquq	30	17	the	the	DT
cord-253746-15w4gquq	30	18	understanding	understanding	NN
cord-253746-15w4gquq	30	19	that	that	IN
cord-253746-15w4gquq	30	20	by	by	IN
cord-253746-15w4gquq	30	21	doing	do	VBG
cord-253746-15w4gquq	30	22	so	so	RB
cord-253746-15w4gquq	30	23	they	-PRON-	PRP
cord-253746-15w4gquq	30	24	contribute	contribute	VBP
cord-253746-15w4gquq	30	25	to	to	TO
cord-253746-15w4gquq	30	26	create	create	VB
cord-253746-15w4gquq	30	27	firm	firm	JJ
cord-253746-15w4gquq	30	28	evidence	evidence	NN
cord-253746-15w4gquq	30	29	regarding	regard	VBG
cord-253746-15w4gquq	30	30	efficacy	efficacy	NN
cord-253746-15w4gquq	30	31	and	and	CC
cord-253746-15w4gquq	30	32	safety	safety	NN
cord-253746-15w4gquq	30	33	of	of	IN
cord-253746-15w4gquq	30	34	the	the	DT
cord-253746-15w4gquq	30	35	new	new	JJ
cord-253746-15w4gquq	30	36	medicines	medicine	NNS
cord-253746-15w4gquq	30	37	they	-PRON-	PRP
cord-253746-15w4gquq	30	38	receive	receive	VBP
cord-253746-15w4gquq	30	39	.	.	.
cord-253746-15w4gquq	31	1	Therefore	therefore	RB
cord-253746-15w4gquq	31	2	,	,	,
cord-253746-15w4gquq	31	3	it	-PRON-	PRP
cord-253746-15w4gquq	31	4	is	be	VBZ
cord-253746-15w4gquq	31	5	essential	essential	JJ
cord-253746-15w4gquq	31	6	that	that	IN
cord-253746-15w4gquq	31	7	trials	trial	NNS
cord-253746-15w4gquq	31	8	are	be	VBP
cord-253746-15w4gquq	31	9	designed	design	VBN
cord-253746-15w4gquq	31	10	to	to	TO
cord-253746-15w4gquq	31	11	include	include	VB
cord-253746-15w4gquq	31	12	sufficient	sufficient	JJ
cord-253746-15w4gquq	31	13	numbers	number	NNS
cord-253746-15w4gquq	31	14	of	of	IN
cord-253746-15w4gquq	31	15	patients	patient	NNS
cord-253746-15w4gquq	31	16	within	within	IN
cord-253746-15w4gquq	31	17	the	the	DT
cord-253746-15w4gquq	31	18	period	period	NN
cord-253746-15w4gquq	31	19	of	of	IN
cord-253746-15w4gquq	31	20	time	time	NN
cord-253746-15w4gquq	31	21	during	during	IN
cord-253746-15w4gquq	31	22	which	which	WDT
cord-253746-15w4gquq	31	23	the	the	DT
cord-253746-15w4gquq	31	24	pandemic	pandemic	NN
cord-253746-15w4gquq	31	25	is	be	VBZ
cord-253746-15w4gquq	31	26	expected	expect	VBN
cord-253746-15w4gquq	31	27	to	to	TO
cord-253746-15w4gquq	31	28	be	be	VB
cord-253746-15w4gquq	31	29	active	active	JJ
cord-253746-15w4gquq	31	30	.	.	.
cord-253746-15w4gquq	32	1	The	the	DT
cord-253746-15w4gquq	32	2	insufficient	insufficient	JJ
cord-253746-15w4gquq	32	3	pace	pace	NN
cord-253746-15w4gquq	32	4	of	of	IN
cord-253746-15w4gquq	32	5	patient	patient	JJ
cord-253746-15w4gquq	32	6	enrollment	enrollment	NN
cord-253746-15w4gquq	32	7	is	be	VBZ
cord-253746-15w4gquq	32	8	indeed	indeed	RB
cord-253746-15w4gquq	32	9	the	the	DT
cord-253746-15w4gquq	32	10	most	most	RBS
cord-253746-15w4gquq	32	11	frequent	frequent	JJ
cord-253746-15w4gquq	32	12	cause	cause	NN
cord-253746-15w4gquq	32	13	of	of	IN
cord-253746-15w4gquq	32	14	trial	trial	NN
cord-253746-15w4gquq	32	15	failure	failure	NN
cord-253746-15w4gquq	32	16	.	.	.
cord-253746-15w4gquq	33	1	This	this	DT
cord-253746-15w4gquq	33	2	has	have	VBZ
cord-253746-15w4gquq	33	3	been	be	VBN
cord-253746-15w4gquq	33	4	a	a	DT
cord-253746-15w4gquq	33	5	matter	matter	NN
cord-253746-15w4gquq	33	6	of	of	IN
cord-253746-15w4gquq	33	7	great	great	JJ
cord-253746-15w4gquq	33	8	concern	concern	NN
cord-253746-15w4gquq	33	9	during	during	IN
cord-253746-15w4gquq	33	10	the	the	DT
cord-253746-15w4gquq	33	11	recent	recent	JJ
cord-253746-15w4gquq	33	12	Ebola	Ebola	NNP
cord-253746-15w4gquq	33	13	virus	virus	NN
cord-253746-15w4gquq	33	14	and	and	CC
cord-253746-15w4gquq	33	15	Zika	Zika	NNP
cord-253746-15w4gquq	33	16	virus	virus	NN
cord-253746-15w4gquq	33	17	outbreak	outbreak	NN
cord-253746-15w4gquq	33	18	(	(	-LRB-
cord-253746-15w4gquq	33	19	8)	8)	NN
cord-253746-15w4gquq	33	20	.	.	.
cord-253746-15w4gquq	34	1	More	More	JJR
cord-253746-15w4gquq	34	2	than	than	IN
cord-253746-15w4gquq	34	3	ever	ever	RB
cord-253746-15w4gquq	34	4	,	,	,
cord-253746-15w4gquq	34	5	there	there	EX
cord-253746-15w4gquq	34	6	is	be	VBZ
cord-253746-15w4gquq	34	7	a	a	DT
cord-253746-15w4gquq	34	8	huge	huge	JJ
cord-253746-15w4gquq	34	9	need	need	NN
cord-253746-15w4gquq	34	10	for	for	IN
cord-253746-15w4gquq	34	11	better	well	JJR
cord-253746-15w4gquq	34	12	coordination	coordination	NN
cord-253746-15w4gquq	34	13	and	and	CC
cord-253746-15w4gquq	34	14	management	management	NN
cord-253746-15w4gquq	34	15	of	of	IN
cord-253746-15w4gquq	34	16	trials	trial	NNS
cord-253746-15w4gquq	34	17	through	through	IN
cord-253746-15w4gquq	34	18	the	the	DT
cord-253746-15w4gquq	34	19	establishment	establishment	NN
cord-253746-15w4gquq	34	20	of	of	IN
cord-253746-15w4gquq	34	21	collaborative	collaborative	JJ
cord-253746-15w4gquq	34	22	infrastructures	infrastructure	NNS
cord-253746-15w4gquq	34	23	and	and	CC
cord-253746-15w4gquq	34	24	platforms	platform	NNS
cord-253746-15w4gquq	34	25	.	.	.
cord-253746-15w4gquq	35	1	In	in	IN
cord-253746-15w4gquq	35	2	this	this	DT
cord-253746-15w4gquq	35	3	regard	regard	NN
cord-253746-15w4gquq	35	4	,	,	,
cord-253746-15w4gquq	35	5	besides	besides	IN
cord-253746-15w4gquq	35	6	the	the	DT
cord-253746-15w4gquq	35	7	ACTIV	ACTIV	NNP
cord-253746-15w4gquq	35	8	program	program	NN
cord-253746-15w4gquq	35	9	in	in	IN
cord-253746-15w4gquq	35	10	the	the	DT
cord-253746-15w4gquq	35	11	US	US	NNP
cord-253746-15w4gquq	35	12	(	(	-LRB-
cord-253746-15w4gquq	35	13	https://bit.ly/32Ct8Fz	https://bit.ly/32ct8fz	NN
cord-253746-15w4gquq	35	14	)	)	-RRB-
cord-253746-15w4gquq	35	15	,	,	,
cord-253746-15w4gquq	35	16	the	the	DT
cord-253746-15w4gquq	35	17	Accelerating	Accelerating	NNP
cord-253746-15w4gquq	35	18	COVID-19	COVID-19	NNP
cord-253746-15w4gquq	35	19	Research	Research	NNP
cord-253746-15w4gquq	35	20	and	and	CC
cord-253746-15w4gquq	35	21	Development	Development	NNP
cord-253746-15w4gquq	35	22	platform	platform	NN
cord-253746-15w4gquq	35	23	(	(	-LRB-
cord-253746-15w4gquq	35	24	ACCORD	ACCORD	NNP
cord-253746-15w4gquq	35	25	)	)	-RRB-
cord-253746-15w4gquq	35	26	in	in	IN
cord-253746-15w4gquq	35	27	the	the	DT
cord-253746-15w4gquq	35	28	UK	UK	NNP
cord-253746-15w4gquq	35	29	(	(	-LRB-
cord-253746-15w4gquq	35	30	https://bit.ly/30vzhRj	https://bit.ly/30vzhrj	UH
cord-253746-15w4gquq	35	31	)	)	-RRB-
cord-253746-15w4gquq	35	32	and	and	CC
cord-253746-15w4gquq	35	33	the	the	DT
cord-253746-15w4gquq	35	34	ERAvsCORONA	eravscorona	NN
cord-253746-15w4gquq	35	35	action	action	NN
cord-253746-15w4gquq	35	36	plan	plan	NN
cord-253746-15w4gquq	35	37	in	in	IN
cord-253746-15w4gquq	35	38	the	the	DT
cord-253746-15w4gquq	35	39	European	European	NNP
cord-253746-15w4gquq	35	40	Union	Union	NNP
cord-253746-15w4gquq	35	41	(	(	-LRB-
cord-253746-15w4gquq	35	42	https://bit.ly/2CBKrfb	https://bit.ly/2CBKrfb	NNP
cord-253746-15w4gquq	35	43	)	)	-RRB-
cord-253746-15w4gquq	35	44	are	be	VBP
cord-253746-15w4gquq	35	45	highly	highly	RB
cord-253746-15w4gquq	35	46	welcome	welcome	JJ
cord-253746-15w4gquq	35	47	initiatives	initiative	NNS
cord-253746-15w4gquq	35	48	.	.	.
cord-253746-15w4gquq	36	1	Regulators	regulator	NNS
cord-253746-15w4gquq	36	2	have	have	VBP
cord-253746-15w4gquq	36	3	also	also	RB
cord-253746-15w4gquq	36	4	an	an	DT
cord-253746-15w4gquq	36	5	important	important	JJ
cord-253746-15w4gquq	36	6	role	role	NN
cord-253746-15w4gquq	36	7	in	in	IN
cord-253746-15w4gquq	36	8	facilitating	facilitate	VBG
cord-253746-15w4gquq	36	9	the	the	DT
cord-253746-15w4gquq	36	10	implementation	implementation	NN
cord-253746-15w4gquq	36	11	of	of	IN
cord-253746-15w4gquq	36	12	sound	sound	JJ
cord-253746-15w4gquq	36	13	clinical	clinical	JJ
cord-253746-15w4gquq	36	14	trials	trial	NNS
cord-253746-15w4gquq	36	15	for	for	IN
cord-253746-15w4gquq	36	16	COVID-19	COVID-19	NNP
cord-253746-15w4gquq	36	17	.	.	.
cord-253746-15w4gquq	37	1	Fortunately	fortunately	RB
cord-253746-15w4gquq	37	2	,	,	,
cord-253746-15w4gquq	37	3	European	european	JJ
cord-253746-15w4gquq	37	4	and	and	CC
cord-253746-15w4gquq	37	5	US	US	NNP
cord-253746-15w4gquq	37	6	regulatory	regulatory	JJ
cord-253746-15w4gquq	37	7	agencies	agency	NNS
cord-253746-15w4gquq	37	8	have	have	VBP
cord-253746-15w4gquq	37	9	issued	issue	VBN
cord-253746-15w4gquq	37	10	guidelines	guideline	NNS
cord-253746-15w4gquq	37	11	for	for	IN
cord-253746-15w4gquq	37	12	clinical	clinical	JJ
cord-253746-15w4gquq	37	13	investigations	investigation	NNS
cord-253746-15w4gquq	37	14	during	during	IN
cord-253746-15w4gquq	37	15	pandemics	pandemic	NNS
cord-253746-15w4gquq	37	16	without	without	IN
cord-253746-15w4gquq	37	17	compromising	compromise	VBG
cord-253746-15w4gquq	37	18	on	on	IN
cord-253746-15w4gquq	37	19	their	-PRON-	PRP$
cord-253746-15w4gquq	37	20	scientific	scientific	JJ
cord-253746-15w4gquq	37	21	validity	validity	NN
cord-253746-15w4gquq	37	22	and	and	CC
cord-253746-15w4gquq	37	23	ethical	ethical	JJ
cord-253746-15w4gquq	37	24	conduct	conduct	NN
cord-253746-15w4gquq	37	25	(	(	-LRB-
cord-253746-15w4gquq	37	26	8)	8)	NN
cord-253746-15w4gquq	37	27	.	.	.
cord-253746-15w4gquq	38	1	Finally	finally	RB
cord-253746-15w4gquq	38	2	,	,	,
cord-253746-15w4gquq	38	3	as	as	IN
cord-253746-15w4gquq	38	4	discussed	discuss	VBN
cord-253746-15w4gquq	38	5	in	in	IN
cord-253746-15w4gquq	38	6	the	the	DT
cord-253746-15w4gquq	38	7	next	next	JJ
cord-253746-15w4gquq	38	8	section	section	NN
cord-253746-15w4gquq	38	9	,	,	,
cord-253746-15w4gquq	38	10	patients	patient	NNS
cord-253746-15w4gquq	38	11	should	should	MD
cord-253746-15w4gquq	38	12	now	now	RB
cord-253746-15w4gquq	38	13	be	be	VB
cord-253746-15w4gquq	38	14	invited	invite	VBN
cord-253746-15w4gquq	38	15	to	to	TO
cord-253746-15w4gquq	38	16	take	take	VB
cord-253746-15w4gquq	38	17	an	an	DT
cord-253746-15w4gquq	38	18	active	active	JJ
cord-253746-15w4gquq	38	19	role	role	NN
cord-253746-15w4gquq	38	20	in	in	IN
cord-253746-15w4gquq	38	21	the	the	DT
cord-253746-15w4gquq	38	22	design	design	NN
cord-253746-15w4gquq	38	23	of	of	IN
cord-253746-15w4gquq	38	24	COVID-19	COVID-19	NNP
cord-253746-15w4gquq	38	25	trials	trial	NNS
cord-253746-15w4gquq	38	26	.	.	.
cord-253746-15w4gquq	39	1	So	so	RB
cord-253746-15w4gquq	39	2	far	far	RB
cord-253746-15w4gquq	39	3	,	,	,
cord-253746-15w4gquq	39	4	patients	patient	NNS
cord-253746-15w4gquq	39	5	enrolled	enrol	VBN
cord-253746-15w4gquq	39	6	in	in	IN
cord-253746-15w4gquq	39	7	the	the	DT
cord-253746-15w4gquq	39	8	trials	trial	NNS
cord-253746-15w4gquq	39	9	mentioned	mention	VBN
cord-253746-15w4gquq	39	10	hereabove	hereabove	NNP
cord-253746-15w4gquq	39	11	did	do	VBD
cord-253746-15w4gquq	39	12	not	not	RB
cord-253746-15w4gquq	39	13	have	have	VB
cord-253746-15w4gquq	39	14	much	much	JJ
cord-253746-15w4gquq	39	15	other	other	JJ
cord-253746-15w4gquq	39	16	option	option	NN
cord-253746-15w4gquq	39	17	than	than	IN
cord-253746-15w4gquq	39	18	signing	sign	VBG
cord-253746-15w4gquq	39	19	the	the	DT
cord-253746-15w4gquq	39	20	informed	inform	VBN
cord-253746-15w4gquq	39	21	-	-	HYPH
cord-253746-15w4gquq	39	22	consent	consent	NN
cord-253746-15w4gquq	39	23	form	form	NN
cord-253746-15w4gquq	39	24	to	to	TO
cord-253746-15w4gquq	39	25	get	get	VB
cord-253746-15w4gquq	39	26	a	a	DT
cord-253746-15w4gquq	39	27	chance	chance	NN
cord-253746-15w4gquq	39	28	to	to	TO
cord-253746-15w4gquq	39	29	receive	receive	VB
cord-253746-15w4gquq	39	30	a	a	DT
cord-253746-15w4gquq	39	31	potentially	potentially	RB
cord-253746-15w4gquq	39	32	life	life	NN
cord-253746-15w4gquq	39	33	-	-	HYPH
cord-253746-15w4gquq	39	34	saving	save	VBG
cord-253746-15w4gquq	39	35	medicine	medicine	NN
cord-253746-15w4gquq	39	36	.	.	.
cord-253746-15w4gquq	40	1	As	as	IN
cord-253746-15w4gquq	40	2	more	more	JJR
cord-253746-15w4gquq	40	3	and	and	CC
cord-253746-15w4gquq	40	4	more	more	JJR
cord-253746-15w4gquq	40	5	patients	patient	NNS
cord-253746-15w4gquq	40	6	will	will	MD
cord-253746-15w4gquq	40	7	be	be	VB
cord-253746-15w4gquq	40	8	diagnosed	diagnose	VBN
cord-253746-15w4gquq	40	9	at	at	IN
cord-253746-15w4gquq	40	10	an	an	DT
cord-253746-15w4gquq	40	11	earlier	early	JJR
cord-253746-15w4gquq	40	12	stage	stage	NN
cord-253746-15w4gquq	40	13	of	of	IN
cord-253746-15w4gquq	40	14	the	the	DT
cord-253746-15w4gquq	40	15	disease	disease	NN
cord-253746-15w4gquq	40	16	or	or	CC
cord-253746-15w4gquq	40	17	with	with	IN
cord-253746-15w4gquq	40	18	a	a	DT
cord-253746-15w4gquq	40	19	milder	mild	JJR
cord-253746-15w4gquq	40	20	form	form	NN
cord-253746-15w4gquq	40	21	of	of	IN
cord-253746-15w4gquq	40	22	COVID-19	COVID-19	NNP
cord-253746-15w4gquq	40	23	,	,	,
cord-253746-15w4gquq	40	24	investigators	investigator	NNS
cord-253746-15w4gquq	40	25	will	will	MD
cord-253746-15w4gquq	40	26	have	have	VB
cord-253746-15w4gquq	40	27	to	to	TO
cord-253746-15w4gquq	40	28	ensure	ensure	VB
cord-253746-15w4gquq	40	29	that	that	IN
cord-253746-15w4gquq	40	30	patients	patient	NNS
cord-253746-15w4gquq	40	31	fully	fully	RB
cord-253746-15w4gquq	40	32	understand	understand	VBP
cord-253746-15w4gquq	40	33	and	and	CC
cord-253746-15w4gquq	40	34	adhere	adhere	VB
cord-253746-15w4gquq	40	35	to	to	IN
cord-253746-15w4gquq	40	36	the	the	DT
cord-253746-15w4gquq	40	37	rationale	rationale	NN
cord-253746-15w4gquq	40	38	of	of	IN
cord-253746-15w4gquq	40	39	the	the	DT
cord-253746-15w4gquq	40	40	proposed	propose	VBN
cord-253746-15w4gquq	40	41	trials	trial	NNS
cord-253746-15w4gquq	40	42	,	,	,
cord-253746-15w4gquq	40	43	their	-PRON-	PRP$
cord-253746-15w4gquq	40	44	expected	expect	VBN
cord-253746-15w4gquq	40	45	benefits	benefit	NNS
cord-253746-15w4gquq	40	46	and	and	CC
cord-253746-15w4gquq	40	47	their	-PRON-	PRP$
cord-253746-15w4gquq	40	48	potential	potential	JJ
cord-253746-15w4gquq	40	49	risks	risk	NNS
cord-253746-15w4gquq	40	50	.	.	.
cord-253746-15w4gquq	41	1	Patients	patient	NNS
cord-253746-15w4gquq	41	2	'	'	POS
cord-253746-15w4gquq	41	3	involvement	involvement	NN
cord-253746-15w4gquq	41	4	in	in	IN
cord-253746-15w4gquq	41	5	medicines	medicine	NNS
cord-253746-15w4gquq	41	6	development	development	NN
cord-253746-15w4gquq	41	7	is	be	VBZ
cord-253746-15w4gquq	41	8	getting	get	VBG
cord-253746-15w4gquq	41	9	more	more	JJR
cord-253746-15w4gquq	41	10	and	and	CC
cord-253746-15w4gquq	41	11	more	more	RBR
cord-253746-15w4gquq	41	12	established	established	JJ
cord-253746-15w4gquq	41	13	in	in	IN
cord-253746-15w4gquq	41	14	both	both	CC
cord-253746-15w4gquq	41	15	academic	academic	JJ
cord-253746-15w4gquq	41	16	and	and	CC
cord-253746-15w4gquq	41	17	industrial	industrial	JJ
cord-253746-15w4gquq	41	18	settings	setting	NNS
cord-253746-15w4gquq	41	19	,	,	,
cord-253746-15w4gquq	41	20	with	with	IN
cord-253746-15w4gquq	41	21	numerous	numerous	JJ
cord-253746-15w4gquq	41	22	publications	publication	NNS
cord-253746-15w4gquq	41	23	showing	show	VBG
cord-253746-15w4gquq	41	24	the	the	DT
cord-253746-15w4gquq	41	25	positive	positive	JJ
cord-253746-15w4gquq	41	26	impact	impact	NN
cord-253746-15w4gquq	41	27	it	-PRON-	PRP
cord-253746-15w4gquq	41	28	might	may	MD
cord-253746-15w4gquq	41	29	have	have	VB
cord-253746-15w4gquq	41	30	(	(	-LRB-
cord-253746-15w4gquq	41	31	9	9	CD
cord-253746-15w4gquq	41	32	,	,	,
cord-253746-15w4gquq	41	33	10	10	CD
cord-253746-15w4gquq	41	34	)	)	-RRB-
cord-253746-15w4gquq	41	35	.	.	.
cord-253746-15w4gquq	42	1	The	the	DT
cord-253746-15w4gquq	42	2	European	European	NNP
cord-253746-15w4gquq	42	3	Patient	Patient	NNP
cord-253746-15w4gquq	42	4	Academy	Academy	NNP
cord-253746-15w4gquq	42	5	of	of	IN
cord-253746-15w4gquq	42	6	Therapeutic	Therapeutic	NNP
cord-253746-15w4gquq	42	7	Innovation	Innovation	NNP
cord-253746-15w4gquq	42	8	(	(	-LRB-
cord-253746-15w4gquq	42	9	EUPATI	EUPATI	NNP
cord-253746-15w4gquq	42	10	)	)	-RRB-
cord-253746-15w4gquq	42	11	launched	launch	VBN
cord-253746-15w4gquq	42	12	by	by	IN
cord-253746-15w4gquq	42	13	the	the	DT
cord-253746-15w4gquq	42	14	Innovative	Innovative	NNP
cord-253746-15w4gquq	42	15	Medicines	Medicines	NNPS
cord-253746-15w4gquq	42	16	Initiative	Initiative	NNP
cord-253746-15w4gquq	42	17	(	(	-LRB-
cord-253746-15w4gquq	42	18	IMI	IMI	NNP
cord-253746-15w4gquq	42	19	)	)	-RRB-
cord-253746-15w4gquq	42	20	is	be	VBZ
cord-253746-15w4gquq	42	21	an	an	DT
cord-253746-15w4gquq	42	22	example	example	NN
cord-253746-15w4gquq	42	23	of	of	IN
cord-253746-15w4gquq	42	24	a	a	DT
cord-253746-15w4gquq	42	25	successful	successful	JJ
cord-253746-15w4gquq	42	26	consortium	consortium	NN
cord-253746-15w4gquq	42	27	that	that	WDT
cord-253746-15w4gquq	42	28	promotes	promote	VBZ
cord-253746-15w4gquq	42	29	patient	patient	JJ
cord-253746-15w4gquq	42	30	participation	participation	NN
cord-253746-15w4gquq	42	31	across	across	IN
cord-253746-15w4gquq	42	32	various	various	JJ
cord-253746-15w4gquq	42	33	stages	stage	NNS
cord-253746-15w4gquq	42	34	in	in	IN
cord-253746-15w4gquq	42	35	the	the	DT
cord-253746-15w4gquq	42	36	drug	drug	NN
cord-253746-15w4gquq	42	37	development	development	NN
cord-253746-15w4gquq	42	38	lifecycle	lifecycle	NN
cord-253746-15w4gquq	42	39	(	(	-LRB-
cord-253746-15w4gquq	42	40	11	11	CD
cord-253746-15w4gquq	42	41	)	)	-RRB-
cord-253746-15w4gquq	42	42	.	.	.
cord-253746-15w4gquq	43	1	This	this	DT
cord-253746-15w4gquq	43	2	is	be	VBZ
cord-253746-15w4gquq	43	3	essential	essential	JJ
cord-253746-15w4gquq	43	4	to	to	TO
cord-253746-15w4gquq	43	5	ensure	ensure	VB
cord-253746-15w4gquq	43	6	that	that	IN
cord-253746-15w4gquq	43	7	patients	patient	NNS
cord-253746-15w4gquq	43	8	'	'	POS
cord-253746-15w4gquq	43	9	expectations	expectation	NNS
cord-253746-15w4gquq	43	10	from	from	IN
cord-253746-15w4gquq	43	11	novel	novel	JJ
cord-253746-15w4gquq	43	12	therapeutics	therapeutic	NNS
cord-253746-15w4gquq	43	13	are	be	VBP
cord-253746-15w4gquq	43	14	at	at	IN
cord-253746-15w4gquq	43	15	the	the	DT
cord-253746-15w4gquq	43	16	center	center	NN
cord-253746-15w4gquq	43	17	of	of	IN
cord-253746-15w4gquq	43	18	trials	trial	NNS
cord-253746-15w4gquq	43	19	'	'	POS
cord-253746-15w4gquq	43	20	objectives	objective	NNS
cord-253746-15w4gquq	43	21	.	.	.
cord-253746-15w4gquq	44	1	Now	now	RB
cord-253746-15w4gquq	44	2	is	be	VBZ
cord-253746-15w4gquq	44	3	the	the	DT
cord-253746-15w4gquq	44	4	time	time	NN
cord-253746-15w4gquq	44	5	to	to	TO
cord-253746-15w4gquq	44	6	apply	apply	VB
cord-253746-15w4gquq	44	7	this	this	DT
cord-253746-15w4gquq	44	8	principle	principle	NN
cord-253746-15w4gquq	44	9	in	in	IN
cord-253746-15w4gquq	44	10	the	the	DT
cord-253746-15w4gquq	44	11	search	search	NN
cord-253746-15w4gquq	44	12	for	for	IN
cord-253746-15w4gquq	44	13	novel	novel	JJ
cord-253746-15w4gquq	44	14	treatments	treatment	NNS
cord-253746-15w4gquq	44	15	and	and	CC
cord-253746-15w4gquq	44	16	vaccines	vaccine	NNS
cord-253746-15w4gquq	44	17	against	against	IN
cord-253746-15w4gquq	44	18	COVID-19	COVID-19	NNP
cord-253746-15w4gquq	44	19	.	.	.
cord-253746-15w4gquq	45	1	Facing	face	VBG
cord-253746-15w4gquq	45	2	the	the	DT
cord-253746-15w4gquq	45	3	tsunami	tsunami	NN
cord-253746-15w4gquq	45	4	of	of	IN
cord-253746-15w4gquq	45	5	informations	information	NNS
cord-253746-15w4gquq	45	6	becoming	become	VBG
cord-253746-15w4gquq	45	7	available	available	JJ
cord-253746-15w4gquq	45	8	every	every	DT
cord-253746-15w4gquq	45	9	day	day	NN
cord-253746-15w4gquq	45	10	about	about	IN
cord-253746-15w4gquq	45	11	SARS	SARS	NNP
cord-253746-15w4gquq	45	12	-	-	HYPH
cord-253746-15w4gquq	45	13	CoV-2	CoV-2	NNP
cord-253746-15w4gquq	45	14	and	and	CC
cord-253746-15w4gquq	45	15	COVID-19	COVID-19	NNP
cord-253746-15w4gquq	45	16	,	,	,
cord-253746-15w4gquq	45	17	patients	patient	NNS
cord-253746-15w4gquq	45	18	'	'	POS
cord-253746-15w4gquq	45	19	input	input	NN
cord-253746-15w4gquq	45	20	is	be	VBZ
cord-253746-15w4gquq	45	21	also	also	RB
cord-253746-15w4gquq	45	22	essential	essential	JJ
cord-253746-15w4gquq	45	23	to	to	TO
cord-253746-15w4gquq	45	24	determine	determine	VB
cord-253746-15w4gquq	45	25	what	what	WDT
cord-253746-15w4gquq	45	26	type	type	NN
cord-253746-15w4gquq	45	27	of	of	IN
cord-253746-15w4gquq	45	28	information	information	NN
cord-253746-15w4gquq	45	29	is	be	VBZ
cord-253746-15w4gquq	45	30	relevant	relevant	JJ
cord-253746-15w4gquq	45	31	and	and	CC
cord-253746-15w4gquq	45	32	how	how	WRB
cord-253746-15w4gquq	45	33	it	-PRON-	PRP
cord-253746-15w4gquq	45	34	should	should	MD
cord-253746-15w4gquq	45	35	be	be	VB
cord-253746-15w4gquq	45	36	communicated	communicate	VBN
cord-253746-15w4gquq	45	37	(	(	-LRB-
cord-253746-15w4gquq	45	38	12	12	CD
cord-253746-15w4gquq	45	39	)	)	-RRB-
cord-253746-15w4gquq	45	40	.	.	.
cord-253746-15w4gquq	46	1	In	in	IN
cord-253746-15w4gquq	46	2	order	order	NN
cord-253746-15w4gquq	46	3	to	to	TO
cord-253746-15w4gquq	46	4	take	take	VB
cord-253746-15w4gquq	46	5	advantage	advantage	NN
cord-253746-15w4gquq	46	6	of	of	IN
cord-253746-15w4gquq	46	7	the	the	DT
cord-253746-15w4gquq	46	8	current	current	JJ
cord-253746-15w4gquq	46	9	window	window	NN
cord-253746-15w4gquq	46	10	of	of	IN
cord-253746-15w4gquq	46	11	opportunity	opportunity	NN
cord-253746-15w4gquq	46	12	for	for	IN
cord-253746-15w4gquq	46	13	patient	patient	NN
cord-253746-15w4gquq	46	14	's	's	POS
cord-253746-15w4gquq	46	15	involvement	involvement	NN
cord-253746-15w4gquq	46	16	in	in	IN
cord-253746-15w4gquq	46	17	the	the	DT
cord-253746-15w4gquq	46	18	fight	fight	NN
cord-253746-15w4gquq	46	19	against	against	IN
cord-253746-15w4gquq	46	20	COVID-19	COVID-19	NNP
cord-253746-15w4gquq	46	21	pandemic	pandemic	NN
cord-253746-15w4gquq	46	22	,	,	,
cord-253746-15w4gquq	46	23	one	one	PRP
cord-253746-15w4gquq	46	24	should	should	MD
cord-253746-15w4gquq	46	25	consider	consider	VB
cord-253746-15w4gquq	46	26	the	the	DT
cord-253746-15w4gquq	46	27	various	various	JJ
cord-253746-15w4gquq	46	28	phases	phase	NNS
cord-253746-15w4gquq	46	29	of	of	IN
cord-253746-15w4gquq	46	30	the	the	DT
cord-253746-15w4gquq	46	31	patient	patient	NN
cord-253746-15w4gquq	46	32	journey	journey	NN
cord-253746-15w4gquq	46	33	,	,	,
cord-253746-15w4gquq	46	34	from	from	IN
cord-253746-15w4gquq	46	35	the	the	DT
cord-253746-15w4gquq	46	36	pre	pre	JJ
cord-253746-15w4gquq	46	37	-	-	JJ
cord-253746-15w4gquq	46	38	symptomatic	symptomatic	JJ
cord-253746-15w4gquq	46	39	phase	phase	NN
cord-253746-15w4gquq	46	40	up	up	IN
cord-253746-15w4gquq	46	41	to	to	IN
cord-253746-15w4gquq	46	42	recovery	recovery	NN
cord-253746-15w4gquq	46	43	and	and	CC
cord-253746-15w4gquq	46	44	beyond	beyond	IN
cord-253746-15w4gquq	46	45	.	.	.
cord-253746-15w4gquq	47	1	The	the	DT
cord-253746-15w4gquq	47	2	multisystemic	multisystemic	JJ
cord-253746-15w4gquq	47	3	consequences	consequence	NNS
cord-253746-15w4gquq	47	4	of	of	IN
cord-253746-15w4gquq	47	5	SARS	SARS	NNP
cord-253746-15w4gquq	47	6	-	-	HYPH
cord-253746-15w4gquq	47	7	CoV-2	CoV-2	NNP
cord-253746-15w4gquq	47	8	infection	infection	NN
cord-253746-15w4gquq	47	9	complexifies	complexify	VBZ
cord-253746-15w4gquq	47	10	patient	patient	JJ
cord-253746-15w4gquq	47	11	stratification	stratification	NN
cord-253746-15w4gquq	47	12	and	and	CC
cord-253746-15w4gquq	47	13	delineation	delineation	NN
cord-253746-15w4gquq	47	14	of	of	IN
cord-253746-15w4gquq	47	15	patient	patient	JJ
cord-253746-15w4gquq	47	16	preferences	preference	NNS
cord-253746-15w4gquq	47	17	.	.	.
cord-253746-15w4gquq	48	1	Furthermore	furthermore	RB
cord-253746-15w4gquq	48	2	,	,	,
cord-253746-15w4gquq	48	3	patient	patient	NN
cord-253746-15w4gquq	48	4	reported	report	VBN
cord-253746-15w4gquq	48	5	outcomes	outcome	NNS
cord-253746-15w4gquq	48	6	are	be	VBP
cord-253746-15w4gquq	48	7	essential	essential	JJ
cord-253746-15w4gquq	48	8	to	to	TO
cord-253746-15w4gquq	48	9	assess	assess	VB
cord-253746-15w4gquq	48	10	the	the	DT
cord-253746-15w4gquq	48	11	impact	impact	NN
cord-253746-15w4gquq	48	12	of	of	IN
cord-253746-15w4gquq	48	13	therapeutic	therapeutic	JJ
cord-253746-15w4gquq	48	14	interventions	intervention	NNS
cord-253746-15w4gquq	48	15	on	on	IN
cord-253746-15w4gquq	48	16	the	the	DT
cord-253746-15w4gquq	48	17	long	long	JJ
cord-253746-15w4gquq	48	18	-	-	HYPH
cord-253746-15w4gquq	48	19	term	term	NN
cord-253746-15w4gquq	48	20	consequences	consequence	NNS
cord-253746-15w4gquq	48	21	of	of	IN
cord-253746-15w4gquq	48	22	COVID-19	COVID-19	NNP
cord-253746-15w4gquq	48	23	(	(	-LRB-
cord-253746-15w4gquq	48	24	13	13	CD
cord-253746-15w4gquq	48	25	)	)	-RRB-
cord-253746-15w4gquq	48	26	.	.	.
cord-253746-15w4gquq	49	1	It	-PRON-	PRP
cord-253746-15w4gquq	49	2	is	be	VBZ
cord-253746-15w4gquq	49	3	therefore	therefore	RB
cord-253746-15w4gquq	49	4	important	important	JJ
cord-253746-15w4gquq	49	5	that	that	IN
cord-253746-15w4gquq	49	6	patient	patient	JJ
cord-253746-15w4gquq	49	7	organizations	organization	NNS
cord-253746-15w4gquq	49	8	are	be	VBP
cord-253746-15w4gquq	49	9	involved	involve	VBN
cord-253746-15w4gquq	49	10	early	early	RB
cord-253746-15w4gquq	49	11	on	on	RB
cord-253746-15w4gquq	49	12	in	in	IN
cord-253746-15w4gquq	49	13	the	the	DT
cord-253746-15w4gquq	49	14	design	design	NN
cord-253746-15w4gquq	49	15	of	of	IN
cord-253746-15w4gquq	49	16	clinical	clinical	JJ
cord-253746-15w4gquq	49	17	trials	trial	NNS
cord-253746-15w4gquq	49	18	.	.	.
cord-253746-15w4gquq	50	1	Finally	finally	RB
cord-253746-15w4gquq	50	2	,	,	,
cord-253746-15w4gquq	50	3	as	as	IN
cord-253746-15w4gquq	50	4	compared	compare	VBN
cord-253746-15w4gquq	50	5	to	to	IN
cord-253746-15w4gquq	50	6	medical	medical	JJ
cord-253746-15w4gquq	50	7	interventions	intervention	NNS
cord-253746-15w4gquq	50	8	for	for	IN
cord-253746-15w4gquq	50	9	other	other	JJ
cord-253746-15w4gquq	50	10	diseases	disease	NNS
cord-253746-15w4gquq	50	11	,	,	,
cord-253746-15w4gquq	50	12	one	one	PRP
cord-253746-15w4gquq	50	13	should	should	MD
cord-253746-15w4gquq	50	14	keep	keep	VB
cord-253746-15w4gquq	50	15	in	in	IN
cord-253746-15w4gquq	50	16	mind	mind	NN
cord-253746-15w4gquq	50	17	that	that	IN
cord-253746-15w4gquq	50	18	during	during	IN
cord-253746-15w4gquq	50	19	a	a	DT
cord-253746-15w4gquq	50	20	pandemic	pandemic	NN
cord-253746-15w4gquq	50	21	every	every	DT
cord-253746-15w4gquq	50	22	citizen	citizen	NN
cord-253746-15w4gquq	50	23	can	can	MD
cord-253746-15w4gquq	50	24	become	become	VB
cord-253746-15w4gquq	50	25	a	a	DT
cord-253746-15w4gquq	50	26	patient	patient	NN
cord-253746-15w4gquq	50	27	from	from	IN
cord-253746-15w4gquq	50	28	1	1	CD
cord-253746-15w4gquq	50	29	day	day	NN
cord-253746-15w4gquq	50	30	to	to	IN
cord-253746-15w4gquq	50	31	the	the	DT
cord-253746-15w4gquq	50	32	other	other	JJ
cord-253746-15w4gquq	50	33	.	.	.
cord-253746-15w4gquq	51	1	This	this	DT
cord-253746-15w4gquq	51	2	has	have	VBZ
cord-253746-15w4gquq	51	3	impact	impact	NN
cord-253746-15w4gquq	51	4	on	on	IN
cord-253746-15w4gquq	51	5	both	both	CC
cord-253746-15w4gquq	51	6	clinical	clinical	JJ
cord-253746-15w4gquq	51	7	trial	trial	NN
cord-253746-15w4gquq	51	8	recruitments	recruitment	NNS
cord-253746-15w4gquq	51	9	and	and	CC
cord-253746-15w4gquq	51	10	behavioral	behavioral	JJ
cord-253746-15w4gquq	51	11	interventions	intervention	NNS
cord-253746-15w4gquq	51	12	to	to	TO
cord-253746-15w4gquq	51	13	reduce	reduce	VB
cord-253746-15w4gquq	51	14	the	the	DT
cord-253746-15w4gquq	51	15	spread	spread	NN
cord-253746-15w4gquq	51	16	of	of	IN
cord-253746-15w4gquq	51	17	the	the	DT
cord-253746-15w4gquq	51	18	disease	disease	NN
cord-253746-15w4gquq	51	19	,	,	,
cord-253746-15w4gquq	51	20	since	since	IN
cord-253746-15w4gquq	51	21	healthy	healthy	JJ
cord-253746-15w4gquq	51	22	people	people	NNS
cord-253746-15w4gquq	51	23	need	need	VBP
cord-253746-15w4gquq	51	24	stronger	strong	JJR
cord-253746-15w4gquq	51	25	incentives	incentive	NNS
cord-253746-15w4gquq	51	26	as	as	IN
cord-253746-15w4gquq	51	27	compared	compare	VBN
cord-253746-15w4gquq	51	28	to	to	IN
cord-253746-15w4gquq	51	29	patients	patient	NNS
cord-253746-15w4gquq	51	30	.	.	.
cord-253746-15w4gquq	52	1	This	this	DT
cord-253746-15w4gquq	52	2	is	be	VBZ
cord-253746-15w4gquq	52	3	especially	especially	RB
cord-253746-15w4gquq	52	4	important	important	JJ
cord-253746-15w4gquq	52	5	to	to	TO
cord-253746-15w4gquq	52	6	ensure	ensure	VB
cord-253746-15w4gquq	52	7	adequate	adequate	JJ
cord-253746-15w4gquq	52	8	vaccine	vaccine	NN
cord-253746-15w4gquq	52	9	coverage	coverage	NN
cord-253746-15w4gquq	52	10	in	in	IN
cord-253746-15w4gquq	52	11	an	an	DT
cord-253746-15w4gquq	52	12	era	era	NN
cord-253746-15w4gquq	52	13	in	in	IN
cord-253746-15w4gquq	52	14	which	which	WDT
cord-253746-15w4gquq	52	15	anti	anti	JJ
cord-253746-15w4gquq	52	16	-	-	JJ
cord-253746-15w4gquq	52	17	vaxx	vaxx	JJ
cord-253746-15w4gquq	52	18	movements	movement	NNS
cord-253746-15w4gquq	52	19	are	be	VBP
cord-253746-15w4gquq	52	20	very	very	RB
cord-253746-15w4gquq	52	21	active	active	JJ
cord-253746-15w4gquq	52	22	and	and	CC
cord-253746-15w4gquq	52	23	vaccine	vaccine	NN
cord-253746-15w4gquq	52	24	hesitancy	hesitancy	NN
cord-253746-15w4gquq	52	25	is	be	VBZ
cord-253746-15w4gquq	52	26	prevalent	prevalent	JJ
cord-253746-15w4gquq	52	27	.	.	.
cord-253746-15w4gquq	53	1	Fostering	foster	VBG
cord-253746-15w4gquq	53	2	health	health	NN
cord-253746-15w4gquq	53	3	literacy	literacy	NN
cord-253746-15w4gquq	53	4	in	in	IN
cord-253746-15w4gquq	53	5	the	the	DT
cord-253746-15w4gquq	53	6	wider	wide	JJR
cord-253746-15w4gquq	53	7	public	public	NN
cord-253746-15w4gquq	53	8	should	should	MD
cord-253746-15w4gquq	53	9	therefore	therefore	RB
cord-253746-15w4gquq	53	10	closely	closely	RB
cord-253746-15w4gquq	53	11	be	be	VB
cord-253746-15w4gquq	53	12	associated	associate	VBN
cord-253746-15w4gquq	53	13	with	with	IN
cord-253746-15w4gquq	53	14	patient	patient	JJ
cord-253746-15w4gquq	53	15	empowerment	empowerment	NN
cord-253746-15w4gquq	53	16	in	in	IN
cord-253746-15w4gquq	53	17	the	the	DT
cord-253746-15w4gquq	53	18	collective	collective	JJ
cord-253746-15w4gquq	53	19	fight	fight	NN
cord-253746-15w4gquq	53	20	against	against	IN
cord-253746-15w4gquq	53	21	COVID-19	COVID-19	NNP
cord-253746-15w4gquq	53	22	.	.	.
cord-253746-15w4gquq	54	1	The	the	DT
cord-253746-15w4gquq	54	2	original	original	JJ
cord-253746-15w4gquq	54	3	contributions	contribution	NNS
cord-253746-15w4gquq	54	4	presented	present	VBN
cord-253746-15w4gquq	54	5	in	in	IN
cord-253746-15w4gquq	54	6	the	the	DT
cord-253746-15w4gquq	54	7	study	study	NN
cord-253746-15w4gquq	54	8	are	be	VBP
cord-253746-15w4gquq	54	9	included	include	VBN
cord-253746-15w4gquq	54	10	in	in	IN
cord-253746-15w4gquq	54	11	the	the	DT
cord-253746-15w4gquq	54	12	article	article	NN
cord-253746-15w4gquq	54	13	/	/	SYM
cord-253746-15w4gquq	54	14	supplementary	supplementary	JJ
cord-253746-15w4gquq	54	15	material	material	NN
cord-253746-15w4gquq	54	16	,	,	,
cord-253746-15w4gquq	54	17	further	further	JJ
cord-253746-15w4gquq	54	18	inquiries	inquiry	NNS
cord-253746-15w4gquq	54	19	can	can	MD
cord-253746-15w4gquq	54	20	be	be	VB
cord-253746-15w4gquq	54	21	directed	direct	VBN
cord-253746-15w4gquq	54	22	to	to	IN
cord-253746-15w4gquq	54	23	the	the	DT
cord-253746-15w4gquq	54	24	corresponding	correspond	VBG
cord-253746-15w4gquq	54	25	author	author	NN
cord-253746-15w4gquq	54	26	/	/	SYM
cord-253746-15w4gquq	54	27	s	s	NN
cord-253746-15w4gquq	54	28	.	.	.
cord-253746-15w4gquq	55	1	Accelerating	accelerate	VBG
cord-253746-15w4gquq	55	2	COVID-19	COVID-19	NNP
cord-253746-15w4gquq	55	3	Therapeutic	Therapeutic	NNP
cord-253746-15w4gquq	55	4	Interventions	Interventions	NNPS
cord-253746-15w4gquq	55	5	and	and	CC
cord-253746-15w4gquq	55	6	Vaccines	Vaccines	NNPS
cord-253746-15w4gquq	55	7	(	(	-LRB-
cord-253746-15w4gquq	55	8	ACTIV	ACTIV	NNP
cord-253746-15w4gquq	55	9	)	)	-RRB-
cord-253746-15w4gquq	56	1	Flooded	flood	VBN
cord-253746-15w4gquq	56	2	by	by	IN
cord-253746-15w4gquq	56	3	the	the	DT
cord-253746-15w4gquq	56	4	torrent	torrent	NN
cord-253746-15w4gquq	56	5	:	:	:
cord-253746-15w4gquq	56	6	the	the	DT
cord-253746-15w4gquq	56	7	COVID	COVID	NNP
cord-253746-15w4gquq	56	8	19	19	CD
cord-253746-15w4gquq	56	9	drug	drug	NN
cord-253746-15w4gquq	56	10	pipeline	pipeline	NN
cord-253746-15w4gquq	56	11	Clinical	clinical	JJ
cord-253746-15w4gquq	56	12	trials	trial	NNS
cord-253746-15w4gquq	56	13	of	of	IN
cord-253746-15w4gquq	56	14	disease	disease	NN
cord-253746-15w4gquq	56	15	stages	stage	NNS
cord-253746-15w4gquq	56	16	in	in	IN
cord-253746-15w4gquq	56	17	COVID	COVID	NNP
cord-253746-15w4gquq	56	18	19	19	CD
cord-253746-15w4gquq	56	19	:	:	:
cord-253746-15w4gquq	56	20	complicated	complicated	JJ
cord-253746-15w4gquq	56	21	and	and	CC
cord-253746-15w4gquq	56	22	often	often	RB
cord-253746-15w4gquq	56	23	misinterpreted	misinterpret	VBD
cord-253746-15w4gquq	56	24	A	a	DT
cord-253746-15w4gquq	56	25	Bayesian	bayesian	JJ
cord-253746-15w4gquq	56	26	adaptive	adaptive	JJ
cord-253746-15w4gquq	56	27	design	design	NN
cord-253746-15w4gquq	56	28	for	for	IN
cord-253746-15w4gquq	56	29	biomarker	biomarker	NN
cord-253746-15w4gquq	56	30	trials	trial	NNS
cord-253746-15w4gquq	56	31	with	with	IN
cord-253746-15w4gquq	56	32	linked	link	VBN
cord-253746-15w4gquq	56	33	treatments	treatment	NNS
cord-253746-15w4gquq	56	34	The	the	DT
cord-253746-15w4gquq	56	35	Recovery	Recovery	NNP
cord-253746-15w4gquq	56	36	Collaborative	Collaborative	NNP
cord-253746-15w4gquq	56	37	Group	Group	NNP
cord-253746-15w4gquq	56	38	.	.	.
cord-253746-15w4gquq	57	1	Effect	effect	NN
cord-253746-15w4gquq	57	2	of	of	IN
cord-253746-15w4gquq	57	3	dexamethasone	dexamethasone	NN
cord-253746-15w4gquq	57	4	in	in	IN
cord-253746-15w4gquq	57	5	hospitalized	hospitalize	VBN
cord-253746-15w4gquq	57	6	patients	patient	NNS
cord-253746-15w4gquq	57	7	with	with	IN
cord-253746-15w4gquq	57	8	COVID-19	covid-19	JJ
cord-253746-15w4gquq	57	9	;	;	:
cord-253746-15w4gquq	57	10	preliminary	preliminary	JJ
cord-253746-15w4gquq	57	11	report	report	NN
cord-253746-15w4gquq	57	12	Remdesivir	Remdesivir	NNP
cord-253746-15w4gquq	57	13	for	for	IN
cord-253746-15w4gquq	57	14	the	the	DT
cord-253746-15w4gquq	57	15	treatment	treatment	NN
cord-253746-15w4gquq	57	16	of	of	IN
cord-253746-15w4gquq	57	17	Covid-19	Covid-19	NNP
cord-253746-15w4gquq	57	18	-Preliminary	-Preliminary	NNP
cord-253746-15w4gquq	57	19	report	report	NN
cord-253746-15w4gquq	57	20	Research	Research	NNP
cord-253746-15w4gquq	57	21	in	in	IN
cord-253746-15w4gquq	57	22	the	the	DT
cord-253746-15w4gquq	57	23	context	context	NN
cord-253746-15w4gquq	57	24	of	of	IN
cord-253746-15w4gquq	57	25	a	a	DT
cord-253746-15w4gquq	57	26	pandemic	pandemic	NN
cord-253746-15w4gquq	57	27	Clinical	clinical	JJ
cord-253746-15w4gquq	57	28	trials	trial	NNS
cord-253746-15w4gquq	57	29	for	for	IN
cord-253746-15w4gquq	57	30	Covid-19	covid-19	NN
cord-253746-15w4gquq	57	31	:	:	:
cord-253746-15w4gquq	57	32	can	can	MD
cord-253746-15w4gquq	57	33	we	-PRON-	PRP
cord-253746-15w4gquq	57	34	better	well	JJR
cord-253746-15w4gquq	57	35	use	use	VB
cord-253746-15w4gquq	57	36	the	the	DT
cord-253746-15w4gquq	57	37	short	short	JJ
cord-253746-15w4gquq	57	38	window	window	NN
cord-253746-15w4gquq	57	39	of	of	IN
cord-253746-15w4gquq	57	40	opportunity	opportunity	NN
cord-253746-15w4gquq	57	41	?	?	.
cord-253746-15w4gquq	58	1	Assessing	assess	VBG
cord-253746-15w4gquq	58	2	the	the	DT
cord-253746-15w4gquq	58	3	financial	financial	JJ
cord-253746-15w4gquq	58	4	value	value	NN
cord-253746-15w4gquq	58	5	of	of	IN
cord-253746-15w4gquq	58	6	patient	patient	NN
cord-253746-15w4gquq	58	7	engagement	engagement	NN
cord-253746-15w4gquq	58	8	:	:	:
cord-253746-15w4gquq	58	9	a	a	DT
cord-253746-15w4gquq	58	10	quantitative	quantitative	JJ
cord-253746-15w4gquq	58	11	approach	approach	NN
cord-253746-15w4gquq	58	12	from	from	IN
cord-253746-15w4gquq	58	13	CTTI	CTTI	NNP
cord-253746-15w4gquq	58	14	's	's	POS
cord-253746-15w4gquq	58	15	patient	patient	NN
cord-253746-15w4gquq	58	16	groups	group	NNS
cord-253746-15w4gquq	58	17	and	and	CC
cord-253746-15w4gquq	58	18	clinical	clinical	JJ
cord-253746-15w4gquq	58	19	trials	trial	NNS
cord-253746-15w4gquq	58	20	project	project	VBP
cord-253746-15w4gquq	58	21	Measuring	measure	VBG
cord-253746-15w4gquq	58	22	the	the	DT
cord-253746-15w4gquq	58	23	impact	impact	NN
cord-253746-15w4gquq	58	24	of	of	IN
cord-253746-15w4gquq	58	25	patient	patient	JJ
cord-253746-15w4gquq	58	26	engagement	engagement	NN
cord-253746-15w4gquq	58	27	and	and	CC
cord-253746-15w4gquq	58	28	patient	patient	JJ
cord-253746-15w4gquq	58	29	centricity	centricity	NN
cord-253746-15w4gquq	58	30	in	in	IN
cord-253746-15w4gquq	58	31	clinical	clinical	JJ
cord-253746-15w4gquq	58	32	research	research	NN
cord-253746-15w4gquq	58	33	and	and	CC
cord-253746-15w4gquq	58	34	development	development	NN
cord-253746-15w4gquq	58	35	Improving	improve	VBG
cord-253746-15w4gquq	58	36	patient	patient	JJ
cord-253746-15w4gquq	58	37	involvement	involvement	NN
cord-253746-15w4gquq	58	38	in	in	IN
cord-253746-15w4gquq	58	39	medicines	medicine	NNS
cord-253746-15w4gquq	58	40	research	research	NN
cord-253746-15w4gquq	58	41	and	and	CC
cord-253746-15w4gquq	58	42	development	development	NN
cord-253746-15w4gquq	58	43	:	:	:
cord-253746-15w4gquq	58	44	:	:	:
cord-253746-15w4gquq	58	45	a	a	DT
cord-253746-15w4gquq	58	46	practical	practical	JJ
cord-253746-15w4gquq	58	47	roadmap	roadmap	NN
cord-253746-15w4gquq	58	48	Improving	improve	VBG
cord-253746-15w4gquq	58	49	clinical	clinical	JJ
cord-253746-15w4gquq	58	50	trial	trial	NN
cord-253746-15w4gquq	58	51	enrollment	enrollment	NN
cord-253746-15w4gquq	58	52	-In	-In	:
cord-253746-15w4gquq	58	53	the	the	DT
cord-253746-15w4gquq	58	54	Covid-19	covid-19	NN
cord-253746-15w4gquq	58	55	era	era	NN
cord-253746-15w4gquq	58	56	and	and	CC
cord-253746-15w4gquq	58	57	beyond	beyond	IN
cord-253746-15w4gquq	58	58	Patient	patient	NN
cord-253746-15w4gquq	58	59	-	-	HYPH
cord-253746-15w4gquq	58	60	reported	report	VBN
cord-253746-15w4gquq	58	61	outcomes	outcome	NNS
cord-253746-15w4gquq	58	62	:	:	:
cord-253746-15w4gquq	58	63	central	central	JJ
cord-253746-15w4gquq	58	64	to	to	IN
cord-253746-15w4gquq	58	65	the	the	DT
cord-253746-15w4gquq	58	66	management	management	NN
cord-253746-15w4gquq	58	67	of	of	IN
cord-253746-15w4gquq	58	68	COVID-19	COVID-19	NNP
cord-253746-15w4gquq	58	69	All	all	DT
cord-253746-15w4gquq	58	70	authors	author	NNS
cord-253746-15w4gquq	58	71	listed	list	VBN
cord-253746-15w4gquq	58	72	have	have	VBP
cord-253746-15w4gquq	58	73	made	make	VBN
cord-253746-15w4gquq	58	74	a	a	DT
cord-253746-15w4gquq	58	75	substantial	substantial	JJ
cord-253746-15w4gquq	58	76	,	,	,
cord-253746-15w4gquq	58	77	direct	direct	JJ
cord-253746-15w4gquq	58	78	and	and	CC
cord-253746-15w4gquq	58	79	intellectual	intellectual	JJ
cord-253746-15w4gquq	58	80	contribution	contribution	NN
cord-253746-15w4gquq	58	81	to	to	IN
cord-253746-15w4gquq	58	82	the	the	DT
cord-253746-15w4gquq	58	83	work	work	NN
cord-253746-15w4gquq	58	84	,	,	,
cord-253746-15w4gquq	58	85	and	and	CC
cord-253746-15w4gquq	58	86	approved	approve	VBD
cord-253746-15w4gquq	58	87	it	-PRON-	PRP
cord-253746-15w4gquq	58	88	for	for	IN
cord-253746-15w4gquq	58	89	publication	publication	NN
cord-253746-15w4gquq	58	90	.	.	.
cord-253746-15w4gquq	59	1	The	the	DT
cord-253746-15w4gquq	59	2	authors	author	NNS
cord-253746-15w4gquq	59	3	declare	declare	VBP
cord-253746-15w4gquq	59	4	that	that	IN
cord-253746-15w4gquq	59	5	the	the	DT
cord-253746-15w4gquq	59	6	research	research	NN
cord-253746-15w4gquq	59	7	was	be	VBD
cord-253746-15w4gquq	59	8	conducted	conduct	VBN
cord-253746-15w4gquq	59	9	in	in	IN
cord-253746-15w4gquq	59	10	the	the	DT
cord-253746-15w4gquq	59	11	absence	absence	NN
cord-253746-15w4gquq	59	12	of	of	IN
cord-253746-15w4gquq	59	13	any	any	DT
cord-253746-15w4gquq	59	14	commercial	commercial	JJ
cord-253746-15w4gquq	59	15	or	or	CC
cord-253746-15w4gquq	59	16	financial	financial	JJ
cord-253746-15w4gquq	59	17	relationships	relationship	NNS
cord-253746-15w4gquq	59	18	that	that	WDT
cord-253746-15w4gquq	59	19	could	could	MD
cord-253746-15w4gquq	59	20	be	be	VB
cord-253746-15w4gquq	59	21	construed	construe	VBN
cord-253746-15w4gquq	59	22	as	as	IN
cord-253746-15w4gquq	59	23	a	a	DT
cord-253746-15w4gquq	59	24	potential	potential	JJ
cord-253746-15w4gquq	59	25	conflict	conflict	NN
cord-253746-15w4gquq	59	26	of	of	IN
cord-253746-15w4gquq	59	27	interest	interest	NN
cord-253746-15w4gquq	59	28	.	.	.
cord-253746-15w4gquq	60	1	Copyright	copyright	NN
cord-253746-15w4gquq	60	2	©	©	NNP
cord-253746-15w4gquq	60	3	2020	2020	CD
cord-253746-15w4gquq	60	4	Goldman	Goldman	NNP
cord-253746-15w4gquq	60	5	and	and	CC
cord-253746-15w4gquq	60	6	Silva	Silva	NNP
cord-253746-15w4gquq	60	7	.	.	.
cord-253746-15w4gquq	61	1	This	this	DT
cord-253746-15w4gquq	61	2	is	be	VBZ
cord-253746-15w4gquq	61	3	an	an	DT
cord-253746-15w4gquq	61	4	open	open	JJ
cord-253746-15w4gquq	61	5	-	-	HYPH
cord-253746-15w4gquq	61	6	access	access	NN
cord-253746-15w4gquq	61	7	article	article	NN
cord-253746-15w4gquq	61	8	distributed	distribute	VBN
cord-253746-15w4gquq	61	9	under	under	IN
cord-253746-15w4gquq	61	10	the	the	DT
cord-253746-15w4gquq	61	11	terms	term	NNS
cord-253746-15w4gquq	61	12	of	of	IN
cord-253746-15w4gquq	61	13	the	the	DT
cord-253746-15w4gquq	61	14	Creative	Creative	NNP
cord-253746-15w4gquq	61	15	Commons	Commons	NNP
cord-253746-15w4gquq	61	16	Attribution	Attribution	NNP
cord-253746-15w4gquq	61	17	License	License	NNP
cord-253746-15w4gquq	61	18	(	(	-LRB-
cord-253746-15w4gquq	61	19	CC	CC	NNP
cord-253746-15w4gquq	61	20	BY	BY	NNP
cord-253746-15w4gquq	61	21	)	)	-RRB-
cord-253746-15w4gquq	61	22	.	.	.
cord-253746-15w4gquq	62	1	The	the	DT
cord-253746-15w4gquq	62	2	use	use	NN
cord-253746-15w4gquq	62	3	,	,	,
cord-253746-15w4gquq	62	4	distribution	distribution	NN
cord-253746-15w4gquq	62	5	or	or	CC
cord-253746-15w4gquq	62	6	reproduction	reproduction	NN
cord-253746-15w4gquq	62	7	in	in	IN
cord-253746-15w4gquq	62	8	other	other	JJ
cord-253746-15w4gquq	62	9	forums	forum	NNS
cord-253746-15w4gquq	62	10	is	be	VBZ
cord-253746-15w4gquq	62	11	permitted	permit	VBN
cord-253746-15w4gquq	62	12	,	,	,
cord-253746-15w4gquq	62	13	provided	provide	VBD
cord-253746-15w4gquq	62	14	the	the	DT
cord-253746-15w4gquq	62	15	original	original	JJ
cord-253746-15w4gquq	62	16	author(s	author(s	NNP
cord-253746-15w4gquq	62	17	)	)	-RRB-
cord-253746-15w4gquq	62	18	and	and	CC
cord-253746-15w4gquq	62	19	the	the	DT
cord-253746-15w4gquq	62	20	copyright	copyright	NN
cord-253746-15w4gquq	62	21	owner(s	owner(s	NNP
cord-253746-15w4gquq	62	22	)	)	-RRB-
cord-253746-15w4gquq	62	23	are	be	VBP
cord-253746-15w4gquq	62	24	credited	credit	VBN
cord-253746-15w4gquq	62	25	and	and	CC
cord-253746-15w4gquq	62	26	that	that	IN
cord-253746-15w4gquq	62	27	the	the	DT
cord-253746-15w4gquq	62	28	original	original	JJ
cord-253746-15w4gquq	62	29	publication	publication	NN
cord-253746-15w4gquq	62	30	in	in	IN
cord-253746-15w4gquq	62	31	this	this	DT
cord-253746-15w4gquq	62	32	journal	journal	NN
cord-253746-15w4gquq	62	33	is	be	VBZ
cord-253746-15w4gquq	62	34	cited	cite	VBN
cord-253746-15w4gquq	62	35	,	,	,
cord-253746-15w4gquq	62	36	in	in	IN
cord-253746-15w4gquq	62	37	accordance	accordance	NN
cord-253746-15w4gquq	62	38	with	with	IN
cord-253746-15w4gquq	62	39	accepted	accepted	JJ
cord-253746-15w4gquq	62	40	academic	academic	JJ
cord-253746-15w4gquq	62	41	practice	practice	NN
cord-253746-15w4gquq	62	42	.	.	.
cord-253746-15w4gquq	63	1	No	no	DT
cord-253746-15w4gquq	63	2	use	use	NN
cord-253746-15w4gquq	63	3	,	,	,
cord-253746-15w4gquq	63	4	distribution	distribution	NN
cord-253746-15w4gquq	63	5	or	or	CC
cord-253746-15w4gquq	63	6	reproduction	reproduction	NN
cord-253746-15w4gquq	63	7	is	be	VBZ
cord-253746-15w4gquq	63	8	permitted	permit	VBN
cord-253746-15w4gquq	63	9	which	which	WDT
cord-253746-15w4gquq	63	10	does	do	VBZ
cord-253746-15w4gquq	63	11	not	not	RB
cord-253746-15w4gquq	63	12	comply	comply	VB
cord-253746-15w4gquq	63	13	with	with	IN
cord-253746-15w4gquq	63	14	these	these	DT
cord-253746-15w4gquq	63	15	terms	term	NNS
cord-253746-15w4gquq	63	16	.	.	.